# EDGAR Filing Document

**Accession Number:** 0001640967
**File Stem:** 0001628280-25-039176
**Filing Date:** 2025-8
**Character Count:** 144401
**Document Hash:** e57b096fb9af073326887c7e5b20d4a7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-25-039176.hdr.sgml**: 20250808

**ACCESSION NUMBER**: 0001628280-25-039176

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 75

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250808

**DATE AS OF CHANGE**: 20250808

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Rise Companies Corp
- **CENTRAL INDEX KEY:** 0001640967
- **STANDARD INDUSTRIAL CLASSIFICATION:** REAL ESTATE INVESTMENT TRUSTS [6798]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 454862460
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56741
- **FILM NUMBER:** 251197085

**BUSINESS ADDRESS:**
- **STREET 1:** 11 DUPONT CIRCLE NW
- **STREET 2:** 9TH FLOOR
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20036
- **BUSINESS PHONE:** 2025840550

**MAIL ADDRESS:**
- **STREET 1:** 11 DUPONT CIRCLE NW
- **STREET 2:** 9TH FLOOR
- **CITY:** WASHINGTON
- **STATE:** DC
- **ZIP:** 20036

?xml version='1.0' encoding='ASCII'? rc-20250630

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549**

**FORM 10-Q**

**(Mark One)**

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

**For the quarterly period ended June 30, 2025**

**or**

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

**For the transition period from ______ to ______**

**Commission file number 000-56741**

**Rise Companies Corp.**

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **45-4862460** |
| (State or other jurisdiction of<br>incorporation or organization) | (I.R.S. Employer<br>Identification No.) |
| **11 Dupont Circle NW, 9**<sup>th</sup> **Floor**<br>**Washington, DC**<br>(Address of Principal Executive Offices) | **20036**<br>(Zip Code) |

---

**(202) 584-0550**

Registrant's telephone number, including area code

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol | Name of each exchange on which registered |
| **None** | **None** | **None** |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| | | Emerging growth company | ☒ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of August 6, 2025, there were 2,458,394 shares of Rise Companies Corp.'s Class A Common Stock outstanding, 20,033,366 shares of Rise Companies Corp.'s Class B Common Stock outstanding, and 10,000,000 shares of Rise Companies Corp.'s Class F Common Stock outstanding.

------

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| | | **Page** |
| <u>[Statements Regarding Forward-Looking Information](#i5cbf7481bb95420f96a80d958b433a8c_7)</u> | <u>[Statements Regarding Forward-Looking Information](#i5cbf7481bb95420f96a80d958b433a8c_7)</u> | <u>[1](#i5cbf7481bb95420f96a80d958b433a8c_7)</u> |
| **<u>[PART I](#i5cbf7481bb95420f96a80d958b433a8c_10)</u>** | **<u>[FINANCIAL INFORMATION](#i5cbf7481bb95420f96a80d958b433a8c_10)</u>**  | <u>[3](#i5cbf7481bb95420f96a80d958b433a8c_10)</u> |
| <u>[Item 1.](#i5cbf7481bb95420f96a80d958b433a8c_13)</u> | <u>[Unaudited Financial Statements](#i5cbf7481bb95420f96a80d958b433a8c_13)</u> | <u>[3](#i5cbf7481bb95420f96a80d958b433a8c_13)</u> |
| <u>[Item 2.](#i5cbf7481bb95420f96a80d958b433a8c_16)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i5cbf7481bb95420f96a80d958b433a8c_16)</u> | <u>[23](#i5cbf7481bb95420f96a80d958b433a8c_16)</u> |
| <u>[Item 3.](#i5cbf7481bb95420f96a80d958b433a8c_19)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i5cbf7481bb95420f96a80d958b433a8c_19)</u> | <u>[30](#i5cbf7481bb95420f96a80d958b433a8c_19)</u> |
| <u>[Item 4.](#i5cbf7481bb95420f96a80d958b433a8c_22)</u> | <u>[Controls and Procedures](#i5cbf7481bb95420f96a80d958b433a8c_22)</u> | <u>[30](#i5cbf7481bb95420f96a80d958b433a8c_22)</u> |
| **<u>[PART II](#i5cbf7481bb95420f96a80d958b433a8c_25)</u>** | **<u>[OTHER INFORMATION](#i5cbf7481bb95420f96a80d958b433a8c_25)</u>**  | <u>[32](#i5cbf7481bb95420f96a80d958b433a8c_25)</u> |
| <u>[Item 1.](#i5cbf7481bb95420f96a80d958b433a8c_28)</u> | <u>[Legal Proceedings](#i5cbf7481bb95420f96a80d958b433a8c_28)</u> | <u>[32](#i5cbf7481bb95420f96a80d958b433a8c_28)</u> |
| <u>[Item 1A.](#i5cbf7481bb95420f96a80d958b433a8c_31)</u> | <u>[Risk Factors](#i5cbf7481bb95420f96a80d958b433a8c_31)</u> | <u>[32](#i5cbf7481bb95420f96a80d958b433a8c_31)</u> |
| <u>[Item 2.](#i5cbf7481bb95420f96a80d958b433a8c_34)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i5cbf7481bb95420f96a80d958b433a8c_34)</u> | <u>[32](#i5cbf7481bb95420f96a80d958b433a8c_34)</u> |
| <u>[Item 3.](#i5cbf7481bb95420f96a80d958b433a8c_37)</u> | <u>[Defaults Upon Senior Securities](#i5cbf7481bb95420f96a80d958b433a8c_37)</u> | <u>[32](#i5cbf7481bb95420f96a80d958b433a8c_37)</u> |
| <u>[Item 4.](#i5cbf7481bb95420f96a80d958b433a8c_40)</u> | <u>[Mine Safety Disclosures](#i5cbf7481bb95420f96a80d958b433a8c_40)</u> | <u>[33](#i5cbf7481bb95420f96a80d958b433a8c_40)</u> |
| <u>[Item 5.](#i5cbf7481bb95420f96a80d958b433a8c_43)</u> | <u>[Other Information](#i5cbf7481bb95420f96a80d958b433a8c_43)</u> | <u>[33](#i5cbf7481bb95420f96a80d958b433a8c_43)</u> |
| <u>[Item 6.](#i5cbf7481bb95420f96a80d958b433a8c_46)</u> | <u>[Exhibits](#i5cbf7481bb95420f96a80d958b433a8c_46)</u> | <u>[33](#i5cbf7481bb95420f96a80d958b433a8c_46)</u> |
| <u>[Signatures](#i5cbf7481bb95420f96a80d958b433a8c_49)</u> | <u>[Signatures](#i5cbf7481bb95420f96a80d958b433a8c_49)</u> | <u>[34](#i5cbf7481bb95420f96a80d958b433a8c_49)</u> |

---

i

------

**STATEMENTS REGARDING FORWARD-LOOKING INFORMATION**

Rise Companies Corp. ("Rise," "Rise Companies," "we," "our," the "Company," and "us") makes statements in this Quarterly Report on Form 10-Q (the "Quarterly Report") that are considered "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The words "believe," "estimate," "expect," "anticipate," "intend," "plan," "seek," "may," and similar expressions or statements regarding future periods are intended to identify forward-looking statements. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and are including this statement for purposes of complying with those safe harbor provisions. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause our actual results, performance or achievements, or industry results, to differ materially from any predictions of future results, performance or achievements that we express or imply in this Quarterly Report or in the information incorporated by reference into this Quarterly Report.

The forward-looking statements included in this Quarterly Report are based upon our current expectations, plans, estimates, assumptions and beliefs that involve numerous risks and uncertainties, and accordingly we can give no assurance that such expectations, plans, estimates, assumptions and beliefs are correct or will be achieved. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond our control. Although we believe that the expectations reflected in such forward-looking statements are based on reasonable assumptions, our actual results and performance may differ materially from those set forth in the forward-looking statements. Factors that could have a material adverse effect on our and our Investment Products' (as defined within *<u>[Note 1](#i5cbf7481bb95420f96a80d958b433a8c_70)</u>, Formation and Organization,* in our condensed consolidated financial statements) operations and future prospects include, but are not limited to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our dependence on fee income generated from our Investment Products to support our continued growth and expansion;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to attract and retain shareholders to the online investment platform located at *<u>www.fundrise.com</u>* (the "Fundrise Platform");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with breaches of our data security;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in geopolitical and economic conditions generally and the real estate and securities markets specifically;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• limited ability of our Investment Products to dispose of assets because of the relative illiquidity of real estate investments;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• intense competition in the real estate market that may limit the ability of our Investment Products to attract or retain tenants or re-lease space;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• increased inflation and related impacts, increased interest rates and operating costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to retain our executive officers and other key personnel of our advisor and our other affiliates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to retain and hire competent employees and appropriately staff our operations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in business conditions and the market value of our and our Investment Products' assets, including changes in interest rates, prepayment risk, operator or borrower defaults or bankruptcy, and generally the increased risk of loss if our investments fail to perform as expected;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to implement effective conflicts of interest policies and procedures among the various investment opportunities sponsored by the Company;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the ability of our Investment Products to access sources of liquidity when we have the need to fund redemptions of common shares in excess of the proceeds from the sales of their common shares in our offerings or funds from our operations and the consequential risk that we may not have the resources to satisfy redemption requests;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our compliance with applicable local, state and federal laws, including the Investment Advisers Act of 1940, as amended (the "Advisers Act"), the Investment Company Act of 1940, as amended (the "Investment Company Act") and other laws; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the other risks identified in this Quarterly Report and our Registration Statement on Form 10-12G, as amended, filed with the Securities and Exchange Commission ("SEC") on June 23, 2025 (the "Form 10"), which may be accessed <u>[here](https://www.sec.gov/Archives/edgar/data/1640967/000162828025032586/risecompaniescorp-form10a2.htm)</u>, including, without limitation, those under headings "Risk Factors" and "Business".

Any of the assumptions underlying forward-looking statements could be inaccurate. You are cautioned not to place undue reliance on any forward-looking statements included in this Quarterly Report. All forward-looking statements are made as of the date of this Quarterly Report and the risk that actual results will differ materially from the expectations expressed in this Quarterly Report will increase with the passage of time. We undertake no obligation to publicly update or revise any forward-looking statements after the date of this Quarterly Report, whether as a result of new information, future events, changed circumstances or any other reason. In light of the significant uncertainties inherent in the forward-looking statements included in this Quarterly Report, the inclusion of such forward-looking statements should not be regarded as a representation by us or any other person that the objectives and plans set forth in this Quarterly Report will be achieved.

------

**PART I - FINANCIAL INFORMATION**

**Item 1. Unaudited Financial Statements.**

**INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF RISE COMPANIES CORP.** 

**(Unaudited)**

---

| | |
|:---|:---|
|  | &nbsp;&nbsp;&nbsp;&nbsp;**<u>Page</u>** |
| <u>[Condensed Consolidated Balance Sheets](#i3297db9fbb2147f981adadc666c709e3)</u> | <u>[4](#i3297db9fbb2147f981adadc666c709e3)</u> |
| <u>[Condensed Consolidated Statements of Operations](#i4d605c67734d456b94817be0f336c3ec)</u> | <u>[5](#i4d605c67734d456b94817be0f336c3ec)</u> |
| <u>[Condensed Consolidated Statements of Changes in Convertible Preferred Stock, Stockholders' Equity and Non-Controlling Interest](#ic9ebb47f9a854f979436be1287f4562b)</u> | <u>[6](#ic9ebb47f9a854f979436be1287f4562b)</u> |
| <u>[Condensed Consolidated Statements of Cash Flows](#i3d209745c9d74e72aac006c4d397c5b2)</u> | <u>[8](#i3d209745c9d74e72aac006c4d397c5b2)</u> |
| <u>[Notes to Condensed Consolidated Financial Statements](#ib0eeed71ca1a40649cf5a2f9218f9354)</u> | <u>[9](#ib0eeed71ca1a40649cf5a2f9218f9354)</u> |

---

------

**RISE COMPANIES CORP.** 

**Condensed Consolidated Balance Sheets** 

*(Amounts in thousands, except share data)*

---

| | | |
|:---|:---|:---|
| | **June 30, 2025**<br>**(Unaudited)** | **December 31, 2024**<br>**(\*)** |
| **<u>ASSETS</u>** | | |
| **Current assets:** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $11231 | $21081 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 304 | 74 |
| &nbsp;&nbsp;&nbsp;&nbsp;Due from affiliates | 6749 | 7147 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses | 1523 | 1619 |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes receivable | 12500 | 12500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets, net | 2571 | 1569 |
| **Total current assets**  | **34878** | **43990** |
| Investments in Sponsored Programs | 1289 | 1248 |
| Property, software and equipment, net | 32909 | 35082 |
| Operating lease assets | 3143 | 3359 |
| Other assets, net | 3456 | 3614 |
| **Total assets** | $**75675** | $**87293** |
| **<u>LIABILITIES</u>** |  |  |
| **Current liabilities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $948 | $947 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | 4758 | 8686 |
| &nbsp;&nbsp;&nbsp;&nbsp;Due to stockholders | 2021 | 1449 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities, current | 1036 | 1023 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loan payable, current |  | 2690 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | 832 | 457 |
| **Total current liabilities**  | **9595** | **15252** |
| Operating lease liabilities, non-current | 3801 | 4153 |
| Other liabilities | 277 | 275 |
| **Total liabilities** | **13673** | **19680** |
| *Commitments and contingencies (<u>[Note 16](#i5cbf7481bb95420f96a80d958b433a8c_118)</u>)* |  |  |
| Series A convertible preferred stock, $0.0001 par value; 15,000,000 shares authorized; 11,865,046 shares issued and outstanding; with an aggregate liquidation preference of $25,951 | 25018 | 25018 |
| **<u>STOCKHOLDERS' EQUITY</u>** |  |  |
| Class A Common Stock, $0.0001 par value; 43,000,000 shares authorized; 2,891,359 shares issued and 2,458,394 shares outstanding, 2,888,859 shares issued and 2,455,894 shares outstanding, respectively |  |  |
| Class B Common Stock, $0.0001 par value; 38,000,000 shares authorized, 21,827,447 shares issued and 19,949,041 outstanding, 21,540,781 shares issued and 20,075,183 outstanding, respectively | 2 | 2 |
| Class F Common Stock, $0.0001 par value; 10,000,000 shares authorized; 10,000,000 shares issued and outstanding | 1 | 1 |
| Additional paid-in capital | 201166 | 200811 |
| Accumulated deficit | (176086) | (169846) |
| **Total stockholders' equity before non-controlling interests**  | **25083** | **30968** |
| Non-controlling interests in consolidated entity | 11901 | 11627 |
| **Total stockholders' equity**  | **36984** | **42595** |
| **Total liabilities and stockholders' equity**  | $**75675** | $**87293** |

---

*\* Derived from audited financials*

*The accompanying notes are an integral part of these condensed consolidated financial statements.*

------

**RISE COMPANIES CORP.** 

**Condensed Consolidated Statements of Operations** 

**(Unaudited)**

*(Amounts in thousands, except share and per share data)*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>June 30,** | **Three Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** | **Six Months Ended<br>June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Revenue** | $**16068** | $**15264** | $**29483** | $**28538** |
| **Costs and expenses** |  |  |  |  |
| Cost of revenue, exclusive of depreciation and amortization shown separately below | 2248 | 2226 | 4466 | 4635 |
| Technology and product development | 4735 | 3378 | 10295 | 7666 |
| Marketing | 1991 | 2011 | 5667 | 4227 |
| General, administrative and other | 6019 | 6018 | 11922 | 12032 |
| Depreciation and amortization | 3030 | 2260 | 6066 | 4674 |
| **Total costs and expenses** | **18023** | **15893** | **38416** | **33234** |
| **Net operating loss** | **(1955)** | **(629)** | **(8933)** | **(4696)** |
| **Other income** |  |  |  |  |
| Gain on extinguishment of debt |  |  | 2391 |  |
| Gain on disposition of investments |  | 587 |  | 587 |
| Dividend and interest income | 253 | 495 | 581 | 1060 |
| Equity in earnings | 30 | 4 | 48 | 25 |
| **Total other income** | **283** | **1086** | **3020** | **1672** |
| **Net income (loss) before income taxes** | **(1672)** | **457** | **(5913)** | **(3024)** |
| Income tax benefit (expense) |  |  |  |  |
| **Net income (loss)** | **(1672)** | **457** | **(5913)** | **(3024)** |
| Net income attributable to non-controlling interests | 165 | 714 | 327 | 847 |
| **Net loss attributable to Rise Companies Corp.** | $**(1837)** | $**(257)** | $**(6240)** | $**(3871)** |
| **Net loss per share attributable to common stockholders:** |  |  |  |  |
| Basic (in dollars per share)\* | $(0.06) | $(0.01) | $(0.19) | $(0.12) |
| Diluted (in dollars per share)\* | (0.06) | (0.01) | (0.19) | (0.12) |
| **Weighted average shares used to compute net loss per share attributable to common stockholders:** |  |  |  |  |
| Basic (in shares)\* | 32506210 | 32933668 | 32526007 | 33020432 |
| Diluted (in shares)\* | 32506210 | 32933668 | 32526007 | 33020432 |

---

__________________

*\*Basic and diluted (loss) per share amounts pertain to each class of Common Stock.*

*The accompanying notes are an integral part of these condensed consolidated financial statements.*

------

**RISE COMPANIES CORP.**

**Condensed Consolidated Statements of Changes in Convertible Preferred Stock, Stockholders' Equity and Non-Controlling Interest**

**(Unaudited)** 

*(Amounts in thousands, except share data)*

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Preferred Stock<br>Series A** | **Preferred Stock<br>Series A** | **Common Stock**<br>**Class A** | **Common Stock**<br>**Class A** | **Common Stock**<br>**Class F** | **Common Stock**<br>**Class F** | **Common Stock**<br>**Class B** | **Common Stock**<br>**Class B** | **Additional Paid-In Capital** | **Accumulated Deficit** | **Non- Controlling Interests** | **Total Equity** |
| | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Additional Paid-In Capital** | **Accumulated Deficit** | **Non- Controlling Interests** | **Total Equity** |
| **Balance at December 31, 2024**  | **11865046** | $**25018** | **2455894** | $**—** | **10000000** | $**1** | **20075183** | $**2** | $**200811** | $**(169846)** | $**11627** | $**42595** |
| Issuance of Class B Common Stock |  |  |  |  |  |  | 60596 |  | 963 |  |  | 963 |
| Redemption of Class B Common Stock  |  |  |  |  |  |  | (202653) |  | (2174) |  |  | (2174) |
| Offering costs for Class B Common Stock  |  |  |  |  |  |  |  |  | (21) |  |  | (21) |
| Exercise of Common A RSOs |  |  | 2500 |  |  |  |  |  | 13 |  |  | 13 |
| Distribution of Member's Equity of NCI |  |  |  |  |  |  |  |  |  |  | (53) | (53) |
| Net income (loss) |  |  |  |  |  |  |  |  |  | (4403) | 162 | (4241) |
| **Balance at March 31, 2025**  | **11865046** | $**25018** | **2458394** | $**—** | **10000000** | $**1** | **19933126** | $**2** | $**199592** | $**(174249)** | $**11736** | $**37082** |
| Issuance of Class B Common Stock |  |  |  |  |  |  | 226070 |  | 3595 |  |  | 3595 |
| Redemption of Class B Common Stock  |  |  |  |  |  |  | (210155) |  | (2020) |  |  | (2020) |
| Offering costs for Class B Common Stock  |  |  |  |  |  |  |  |  | (1) |  |  | (1) |
| Net income (loss) |  |  |  |  |  |  |  |  |  | (1837) | 165 | (1672) |
| **Balance at June 30, 2025** | **11865046** | $**25018** | **2458394** | $**—** | **10000000** | $**1** | **19949041** | $**2** | $**201166** | $**(176086)** | $**11901** | $**36984** |

---

------

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Preferred Stock<br>Series A** | **Preferred Stock<br>Series A** | **Common Stock**<br>**Class A** | **Common Stock**<br>**Class A** | **Common Stock**<br>**Class F** | **Common Stock**<br>**Class F** | **Common Stock**<br>**Class B** | **Common Stock**<br>**Class B** | **Additional Paid-In Capital** | **Accumulated Deficit** | **Non- Controlling Interests** | **Total Equity** |
| | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Shares** | **Amount** | **Additional Paid-In Capital** | **Accumulated Deficit** | **Non- Controlling Interests** | **Total Equity** |
| **Balance at December 31, 2023**  | **11865046** | $**25018** | **2455894** | $**—** | **10000000** | $**1** | **20653333** | $**2** | $**207105** | $**(160828)** | $**10534** | $**56814** |
| Redemption of Class B Common Stock  |  |  |  |  |  |  | (173875) |  | (1873) |  |  | (1873) |
| Offering costs for Class B Common Stock |  |  |  |  |  |  |  |  | (5) |  |  | (5) |
| Distribution of Member's Equity of NCI |  |  |  |  |  |  |  |  |  |  | (54) | (54) |
| Net income (loss) |  |  |  |  |  |  |  |  |  | (3614) | 133 | (3481) |
| **Balance at March 31, 2024** | **11865046** | $**25018** | **2455894** | $**—** | **10000000** | $**1** | **20479458** | $**2** | $**205227** | $**(164442)** | $**10613** | $**51401** |
| Redemption of Class B Common Stock  |  |  |  |  |  |  | (141032) |  | (1493) |  |  | (1493) |
| Offering costs for Class B Common Stock  |  |  |  |  |  |  |  |  | (16) |  |  | (16) |
| Net income (loss) |  |  |  |  |  |  |  |  |  | (257) | 714 | 457 |
| **Balance at June 30, 2024** | **11865046** | $**25018** | **2455894** | $**—** | **10000000** | $**1** | **20338426** | $**2** | $**203718** | $**(164699)** | $**11327** | $**50349** |

---

*The accompanying notes are an integral part of these condensed consolidated financial statements.*

------

**RISE COMPANIES CORP.** 

**Condensed Consolidated Statements of Cash Flows**

**(Unaudited)** 

(*Amounts in thousands*)

---

| | | |
|:---|:---|:---|
| | **Six Months Ended**<br>**June 30, 2025** | **Six Months Ended**<br>**June 30, 2024** |
| **Cash flows from operating activities** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss | $(5913) | $(3024) |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to net cash used in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 6066 | 4674 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Gain) on disposition of investments |  | (587) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Gain) on extinguishment of debt | (2391) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment of long-lived assets |  | 70 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of capitalized promotions | 302 | 315 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other non-cash, net | (11) | 63 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net (increase) decrease in prepaid expenses and other assets | (739) | (587) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in accounts payable and accrued expenses | (3927) | (3474) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net increase (decrease) in other liabilities | 254 | (197) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net (increase) decrease in due from affiliates | 398 | 368 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net (increase) decrease in interest receivable | (320) | (236) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net cash used in operating activities**  | **(6281)** | **(2615)** |
| **Cash flows from investing activities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Capitalized internal-use software development costs | (3841) | (7500) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from disposition of investments |  | 1772 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net | (73) | (63) |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net cash used in investing activities**  | **(3914)** | **(5791)** |
| **Cash flows from financing activities**  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Distribution of Member's Equity of NCI | (53) | (54) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from the issuance of Class B Common Stock, net of offering costs | 4536 | (21) |
| &nbsp;&nbsp;&nbsp;&nbsp;Redemptions of Class B Common Stock | (3622) | (3259) |
| &nbsp;&nbsp;&nbsp;&nbsp;Exercise of Class A Common Stock | 13 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Payment of principal on loan payable | (374) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from settling subscriptions | 75 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Net cash provided by (used in) financing activities**  | **575** | **(3334)** |
| **Net increase (decrease) in cash and cash equivalents**  | **(9620)** | **(11740)** |
| Cash, restricted cash and cash equivalents, beginning of period | 21155 | 41065 |
| **Cash, restricted cash and cash equivalents, end of period**  | $**11535** | $**29325** |

---

---

| | | |
|:---|:---|:---|
| **Supplemental disclosures of cash flow information**  | | |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for interest | $| $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for income taxes |  | 68 |

---

*The accompanying notes are an integral part of these condensed consolidated financial statements.*

------

**RISE COMPANIES CORP.** 

**Notes to Condensed Consolidated Financial Statements**

**(Unaudited)**

**1. Formation and Organization**

Rise Companies Corp. ("Rise," "Rise Companies," "we," "our," the "Company," and "us") is a financial technology company that owns and operates a leading web-based and mobile application direct investment platform located at www.fundrise.com (the "Fundrise Platform").

We operate through the following significant consolidated subsidiaries, with the following activities:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise, LLC ("Fundrise, LLC"), a wholly-owned subsidiary of Rise, owns and operates the Fundrise Platform that allows investors to become equity or debt holders in alternative investment opportunities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Advisors, LLC ("Fundrise Advisors"), a wholly-owned subsidiary of Rise, is a registered investment adviser with the SEC that acts as the non-member manager for the fund programs sponsored by the Company and offered for investment via the Fundrise Platform.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise, L.P. ("Fundrise LP"), is an affiliate of Rise and was created with the intent to directly benefit the Company by driving its growth and profitability primarily through (i) acquisition, lending, holding, and distribution or other disposition of real estate investments, including investments in the Sponsored Programs (as defined below), and (ii) temporarily investing any idle cash. Rise owns approximately 2% of Fundrise LP and has the ability to direct its assets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Real Estate, LLC ("Fundrise Real Estate"), a wholly-owned subsidiary of Rise, is a real estate operating platform through which many of the real estate assets of our Investment Products (as defined below) are managed.

The Company has sponsored the following investment programs as of June 30, 2025, that are registered as investment companies under the Investment Company Act of 1940:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Real Estate Interval Fund, LLC (the "Flagship Fund") is a Delaware limited liability company that is registered under the Investment Company Act, as a non-diversified, closed-end management investment company that is operated as an interval fund.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Income Real Estate Fund, LLC (the "Income Interval Fund") is a Delaware limited liability company that is registered under the Investment Company Act, as a non-diversified, closed-end management investment company that is operated as an interval fund.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Growth Tech Fund, LLC (the "Innovation Fund") is a Delaware limited liability company that is registered under the Investment Company Act, as a non-diversified, closed-end management investment company that is operated as a tender offer fund.

The Company has sponsored the following investment programs that are exempt from registration under the Securities Act of 1933, as amended (the "Securities Act") as of June 30, 2025:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Equity REIT, LLC, Fundrise West Coast Opportunistic REIT, LLC, Fundrise East Coast Opportunistic REIT, LLC, Fundrise Midland Opportunistic REIT, LLC, Fundrise Growth eREIT II, LLC, Fundrise Growth eREIT III, LLC, Fundrise Development eREIT, LLC, Fundrise Growth eREIT VII, LLC and Fundrise Balanced eREIT II, LLC are real estate investment trust programs (the "eREITs"). The eREITs use a typical REIT structure similar to other publicly offered REITs, but are only available to investors via the internet on the Fundrise Platform. "eREIT<sup>®</sup>" is our registered trademark.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Fundrise Equity REIT, LLC, Fundrise Growth eREIT II, LLC, Fundrise Growth eREIT III, LLC, and Fundrise Growth eREIT VII, LLC pursue a strategy focused on long-term capital appreciation with a focus primarily on multifamily and build-for-rent properties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Fundrise West Coast Opportunistic REIT, LLC, Fundrise East Coast Opportunistic REIT, LLC, and Fundrise Midland Opportunistic REIT, LLC pursue a balanced strategy of acquiring both debt and equity investments primarily within the geographic regions reflected in each fund's name. These eREITs focus on multifamily, industrial, and creative office properties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Fundrise Development eREIT, LLC, focuses on renovation and new construction by investing directly in the development of primarily single family, multifamily, commercial, and mixed-use properties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ Fundrise Balanced eREIT II, LLC focuses on newly built multifamily properties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise eFund, LLC, is a real estate investment fund program (the "eFund"). The eFund primarily focuses on single-family rental and industrial properties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Opportunity Fund, LP and Fundrise Opportunity Zone OP, LLC (collectively referred to as the "Opportunity Fund" or the "oFund"), make up a tax-advantaged real estate investment fund program offered under Regulation D of the Securities Act ("Regulation D"). The oFund focuses on high-quality real estate properties located in qualified opportunity zones, as designated under the Internal Revenue Code of 1986, as amended, and is invested in mixed-use development and creative office properties.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Fundrise Opportunistic Credit Fund, LLC (the "Credit Fund") is a Delaware limited liability company offered under Regulation D, that is offered through the Fundrise Platform. The Credit Fund focuses on private credit investments such as preferred equity positions and asset backed securities primarily in the multifamily and single-family rental markets.

The eREITs, eFund, oFund, Credit Fund, Flagship Fund, Income Interval Fund and Innovation Fund are referred to, individually or collectively as the context requires, as the "Sponsored Programs," or the "Investment Products."

**2. Summary of Significant Accounting Policies**

***Basis of Presentation***

The accompanying unaudited condensed consolidated financial statements of the Company are prepared on the accrual basis of accounting and conform to accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial reporting. Accordingly, certain information and note disclosures normally included in the financial statements prepared under U.S. GAAP have been condensed or omitted.

All adjustments considered necessary for a fair presentation of the Company's financial position, results of operations and cash flows have been included and are of a normal and recurring nature. Interim results are not necessarily indicative of operating results for any other interim period or for the entire year. The condensed consolidated balance sheet as of December 31, 2024 and certain related disclosures are derived from the Company's audited consolidated financial statements filed with the Form 10. These condensed consolidated financial statements should be read in conjunction with the Company's consolidated financial statements and notes thereto included in the Form 10. The condensed consolidated financial statements as of June 30, 2025 and for the three and six months ended June 30, 2025 and June 30, 2024, respectively, and certain related disclosures are unaudited and may not include year-end adjustments to make those consolidated financial statements comparable to audited results. Additionally, the significant accounting policies used in the preparation of these condensed consolidated financial statements are disclosed in the notes to the audited consolidated financial statements included in the Form 10. Other than as noted below, the significant accounting policies have not changed significantly.

------

***Principles of Consolidation***

The Company consolidates entities when we own, directly or indirectly, a majority interest in the entity or are otherwise able to control the entity. We consolidate variable interest entities ("VIEs") in accordance with the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") 810, *Consolidation*, if we are the primary beneficiary of the VIE as determined by our power to direct the VIE's activities and the obligation to absorb its losses or the right to receive its benefits, which are potentially significant to the VIE. A VIE is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity's activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity's activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity's activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights.

The Company consolidates Fundrise LP and other wholly-owned entities as it was determined that Rise, together with its subsidiaries, is the primary beneficiary. All intercompany balances and transactions have been eliminated in consolidation. The Company's other disclosures regarding VIEs are discussed in *<u>[Note 14,](#i5cbf7481bb95420f96a80d958b433a8c_112)</u> Variable Interest Entities.*

***Estimates***

The preparation of the condensed consolidated financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and the disclosures of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could materially differ from those estimates.

***Reclassifications***

Certain prior period balances in the statements of operations and statements of cash flows have been combined or reclassified to conform to current period presentation.

The reclassifications in the statements of operations primarily represent changes to the Company's income statement to present Cost of revenue, exclusive of depreciation and amortization, and Depreciation and amortization, and to remove line items for Investment management and platform advisory and Real estate strategy and operations expenses. Additional amounts from Technology and product development, Marketing, and General, administrative and other were reclassified to conform to current period presentation.

Cost of revenue, exclusive of depreciation and amortization, consists primarily of: (i) allocated salaries and benefits for employees responsible for investor relations and service; (ii) salaries and benefits of personnel associated with real estate services such as closing of a real estate investment and real estate asset management; and (iii) costs associated with maintaining the Fundrise Platform including cloud infrastructure costs, third-party expenses, and salaries and benefits of personnel responsible for maintaining our platform.

The Company also combined its revenue streams into one line item (which is further disaggregated in *<u>[Note 4](#i5cbf7481bb95420f96a80d958b433a8c_79)</u>, Revenue*) and reclassified Dividend and interest income from operating revenues to Other income. The Company believes this updated presentation will improve the usefulness of the financial information for the reader and is consistent with the manner in which financial information is reviewed by management for internal decision making. All reclassifications disclosed above had no impact on net income or cash flows previously reported.

***Concentrations of Credit Risk***

Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. To mitigate the risk of concentration associated with cash and cash equivalents, as well as restricted cash, funds are held with creditworthy institutions and, at certain times, temporarily swept into insured

------

programs overnight to reduce single firm concentration risk. Amounts on deposit may exceed federal deposit insurance limits. To date, the Company has not experienced any material losses with respect to cash and cash equivalents.

***Recent Accounting Pronouncements***

In August 2020, the FASB issued ASU No. 2020-06, *Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40)*, which simplifies the accounting for convertible debt instruments and convertible preferred stock by reducing the number of accounting models and limiting the number of embedded conversion features separately recognized from the primary contract. The guidance also includes targeted improvements to the disclosures for convertible instruments and earnings per share. The Company adopted ASU 2020-06 effective January 1, 2024, and adoption did not have a material impact on our consolidated financial statements.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): *Improvements to Reportable Segment Disclosures*, which requires disclosure of incremental segment information on an annual and interim basis, including for public entities with a single reportable segment. The Company adopted ASU 2023-07 for the consolidated annual financial statements as of and for the year ended December 31, 2024. Adoption of ASU 2023-07 required additional disclosures in the financial statements as a result of the new requirements (refer to *<u>[Note 13](#i5cbf7481bb95420f96a80d958b433a8c_109)</u>, Segment and Geographic Information*) and was applied to all periods presented retrospectively by expanding disclosures as required by ASU 2023-07. The adoption of ASU 2023-07 did not have a material impact on our financial statements, as the requirements impact only segment reporting disclosures in the notes to the Company's financial statements.

In December 2023, the FASB issued ASU 2023-09 — Income Taxes (Topic 740): *Improvements to Income Tax Disclosures*. The ASU requires that an entity disclose specific categories in the effective tax rate reconciliation as well as reconciling items that meet a quantitative threshold. Further, the ASU requires additional disclosures on income tax expense and taxes paid, net of refunds received, by jurisdiction. The new standard is effective for public business entities for annual periods beginning after December 15, 2024 (and emerging growth companies for annual periods beginning after December 15, 2025) on a prospective basis with the option to apply it retrospectively. Early adoption is permitted. The adoption of this guidance will result in the Company being required to include enhanced income tax related disclosures. The Company is currently evaluating the impact this standard will have on its financial statements.

In November 2024, the FASB issued ASU 2024-03 — Income Statement — Reporting Comprehensive Income— *Expense Disaggregation Disclosures (Subtopic 220-40)* which requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement as well as disclosures about selling expenses. The new guidance is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. The requirements will be applied prospectively with the option for retrospective application and early adoption is permitted. The Company is in the process of evaluating the potential impact of ASU 2024-03 on its financial statements and related disclosures.

***Emerging Growth Company***

The Company is an "emerging growth company," as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"), until the earlier of (a) the last day of the fiscal year (i) following the fifth anniversary of the date of an initial public offering pursuant to an effective registration statement under the Securities Act, (ii) in which we have total annual gross revenue of at least $1.235 billion, or (iii) in which we are deemed to be a large accelerated filer, which means the market value of our shares that is held by non-affiliates exceeds $700 million as of the date of our most recently completed second fiscal quarter, and (b) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period. For so long as we remain an "emerging growth company" we are eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not "emerging growth companies" including, but not limited to, not being required to comply with the auditor attestation

------

requirements of Section 404 of the Sarbanes-Oxley Act. We cannot predict if investors will find our shares less attractive because we may rely on some or all of these exemptions.

In addition, Section 107 of the JOBS Act also provides that an "emerging growth company" can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an "emerging growth company" can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We will take advantage of the extended transition period for complying with new or revised accounting standards, which may make it more difficult for investors and securities analysts to evaluate us since our financial statements may not be comparable to companies that comply with public company effective dates.

**3. Net Loss Per Share and Net Loss Attributable to Common Stockholders**

The following table presents the calculation of basic and diluted net loss per share attributable to Rise Companies Corp. Class A, Class B, and Class F common stockholders (*in thousands, except share and per share data*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Numerator: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | $(1672) | $457 | $(5913) | $(3024) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Less: net income attributable to noncontrolling interest | 165 | 714 | 327 | 847 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net loss attributable to common stockholders | $(1837) | $(257) | $(6240) | $(3871) |
| Denominator: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Weighted-average common shares outstanding – basic and diluted | 32506210 | 32933668 | 32526007 | 33020432 |
| **Net loss per share attributable to common stockholders - basic and diluted**  | $**(0.06)** | $**(0.01)** | $**(0.19)** | $**(0.12)** |

---

The following potential common shares were excluded from the calculation of diluted net loss per share attributable to Rise Companies Corp. Class A, Class B, and Class F common stockholders because their effect would have been anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period:

---

| | | |
|:---|:---|:---|
| | **Three and Six Months Ended June 30,** | **Three and Six Months Ended June 30,** |
| | **2025** | **2024** |
| Redeemable convertible preferred stock | 11865046 | 11865046 |
| Restricted stock options | 6500 | 11500 |
| Restricted stock units | 8910844 | 8480071 |
| Performance stock units | 3018867 |  |
| **Total anti-dilutive securities**  | **23801257** | **20356617** |

---

------

**4. Revenue**

The following table presents the Company's net revenue disaggregated by category (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Revenue:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment management and platform advisory, net | $8003 | $7719 | $15826 | $15410 |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate management | 3432 | 3031 | 4380 | 4293 |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate operating platform | 4633 | 4514 | 9277 | 8835 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Total revenue** | $**16068** | $**15264** | $**29483** | $**28538** |

---

**5. Fair Value of Financial Instruments**

We are required to disclose an estimate of fair value of our financial instruments for which it is practicable to estimate the value. U.S. GAAP defines the fair value as the price that the Company would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. For certain of our financial instruments, fair values are not readily available since there are no active trading markets as characterized by current exchanges by willing parties.

We determine the fair value of certain investments in accordance with the fair value hierarchy that requires an entity to maximize the use of observable inputs. The fair value hierarchy includes the following three levels based on the objectivity of the inputs, which were used for categorizing the assets or liabilities for which fair value is being measured and reported:

Level 1 – Quoted market prices in active markets for identical assets or liabilities.

Level 2 – Significant other observable inputs (e.g., quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs).

Level 3 – Valuation generated from model-based techniques that use inputs that are significant and unobservable in the market. These unobservable assumptions reflect estimates of inputs that market participants would use in pricing the asset or liability. Valuation techniques include use of option pricing models, discounted cash flow methodologies or similar techniques, which incorporate management's own estimates of assumptions that market participants would use in pricing the instrument or valuations that require significant management judgment or estimation.

As of June 30, 2025, the Company's significant financial instruments consist of cash and cash equivalents and notes receivable. As of December 31, 2024, the Company's significant financial instruments consist of cash and cash equivalents, loan payable, and notes receivable. For all instruments in both periods, the carrying amount of the Company's financial instruments approximates their fair values due to their short-term nature.

Refer to *<u>[Note 10](#i5cbf7481bb95420f96a80d958b433a8c_100)</u>, Stock-Based Compensation and Other Employee Benefits*, for more information on the fair value inputs used to calculate the grant date fair values of the Company's stock-based awards.

**6. Leases**

On January 8, 2019, the Company entered into a ten-year non-cancelable operating lease agreement, expiring on August 31, 2030, for office space located at 11 Dupont Circle NW, Washington, DC 20036. The lease includes one option to renew, but the renewal is not deemed to be reasonably assured as of June 30, 2025. Our lease agreement does not contain any material residual value guarantees or material restrictive covenants.

Operating lease expense was $200,000 for the three months ended June 30, 2025 and 2024 and $401,000 for the six months ended June 30, 2025 and 2024, respectively.

------

As of June 30, 2025, our lease had a remaining lease term of 5.2 years and a discount rate of 7.50%. Future lease payments as of June 30, 2025 were as follows (*in thousands*):

---

| | |
|:---|:---|
| | **Operating**<br> **Leases** |
| 2025 | $535 |
| 2026 | 1086 |
| 2027 | 1113 |
| 2028 | 1140 |
| 2029 | 1169 |
| Thereafter | 795 |
| Total future lease payments | 5838 |
| Less: Imputed interest | 1001 |
| **Present value of lease liabilities**  | $**4837** |
| Lease liabilities, current | 1036 |
| Lease liabilities, non-current | 3801 |
| **Present value of lease liabilities**  | $**4837** |

---

Other information related to our lease for the three and six months ended June 30, 2025 and 2024 is as follows (*in thousands*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended June 30,** | **Three Months Ended June 30,** | **Six Months Ended June 30,** | **Six Months Ended June 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |  |
| Operating cash flows | $263 | 256 | 524 | 511 |

---

**7. Property, Software and Equipment, net**

Property, software and equipment, net, consist of the following (*in thousands*):

---

| | | |
|:---|:---|:---|
| | **June 30, 2025** | **December 31, 2024** |
| Internal-use software | $65315 | $61476 |
| Computer equipment | 719 | 688 |
| Furniture and fixtures | 240 | 240 |
| Leasehold Improvements | 1668 | 1668 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total property, software and equipment | 67942 | 64072 |
| Less: accumulated amortization and depreciation | (35033) | (28990) |
| **Total property, software and equipment, net**  | $**32909** | $**35082** |

---

Amortization and depreciation expense on property, software and equipment was approximately $3,027,000 and $2,258,000 for the three months ended June 30, 2025 and 2024, respectively, and $6,061,000 and $4,668,000 for the six months ended June 30, 2025 and 2024, respectively. Included in these amounts were the amortization of capitalized internal-use software costs of approximately $2,949,000 and $2,171,000, for the three months ended June 30, 2025 and 2024, respectively, and $5,904,000 and $4,493,000 for the six months ended June 30, 2025 and 2024, respectively.

There were no write-offs of internal-use software or resulting impairment losses recorded for the three months and six months ended June 30, 2025. The Company wrote off $70,000 of internal-use software for the six months

------

ended June 30, 2024. The resulting impairment loss of $70,000 for the six months ended June 30, 2024 is included in Technology and product development on the condensed consolidated statements of operations. There were no write-offs of internal-use software or resulting impairment losses recorded for the three months ended June 30, 2024.

**8. Loan Payable**

***PPP Loan Payable***

On April 20, 2020, the Company received a Paycheck Protection Program loan (the "PPP Loan") from Citizens Bank under the Coronavirus Aid, Relief and Economic Security Act (the "CARES Act") in the principal amount of $2,793,800, bearing interest at a fixed rate of 1% per annum. The loan's initial maturity date of April 19, 2022 was extended to April 19, 2025.

In July 2021, the Company applied for forgiveness of the PPP Loan. In January 2025, the Company was notified that $2,315,905 of the loan principal and related accrued interest was forgiven. The Company recorded a gain from debt extinguishment with respect to such loan forgiveness in its condensed consolidated statement of operations for the six months ended June 30, 2025. The remaining principal outstanding was paid during the six months ended June 30, 2025.

As of December 31, 2024, the remaining outstanding principal of the PPP Loan was $2,690,000, with accrued interest of $75,000, which is recorded in Other current liabilities in the condensed consolidated balance sheets.

**9. Supplemental Financial Statement Information**

***Accrued Expenses***

Accrued expenses consist of the following (*in thousands*):

---

| | | |
|:---|:---|:---|
| | **June 30, 2025** | **December 31, 2024** |
| Accrued compensation and employee benefits | $3709 | $7556 |
| Accrued deferred costs of Sponsored Programs | 44 | 626 |
| Accrued legal expenses | 758 | 75 |
| Accrued audit and tax expenses | 164 | 279 |
| Other accrued expenses | 83 | 150 |
| **Total**  | $**4758** | $**8686** |

---

**10. Stock-Based Compensation and Other Employee Benefits**

***Stock-Based Compensation***

Under our 2014 Stock Option and Grant Plan, we may grant unrestricted stock grants, restricted stock grants ("RSGs"), restricted stock units ("RSUs"), restricted stock options ("RSOs"), performance stock units ("PSUs"), and other types of awards as specified in the plan to provide shares of Common Stock to employees, executives, directors, and consultants, subject to applicable vesting. A total of 20,100,000 shares of Class A Common Stock have been authorized for issuance under the 2014 Stock Option and Grant Plan, as amended (the "Plan") as of June 30, 2025 and December 31, 2024. The Company has issued RSGs, RSUs, RSOs, and PSUs as of June 30, 2025.

The Company issued no RSGs and no shares were forfeited for the three and six months ended June 30, 2025 and 2024. The Company issued no RSOs for the three and six months ended June 30, 2025 and 2024. During the three and six months ended June 30, 2025, zero and 2,500 outstanding RSOs were forfeited, respectively. No RSOs were forfeited during the three and six months ended June 30, 2024. The Company recognized $0 of stock-based compensation expense related to RSGs and RSOs during the three and six months ended June 30, 2025 and 2024, respectively. As of both June 30, 2025 and December 31, 2024, there were no remaining unvested shares and no unrecognized stock-based compensation expense related to RSGs or RSOs. During the six months ended June 30,

------

2025, one former employee exercised 2,500 shares of outstanding RSOs at an exercise price of $5.25 per share. As of June 30, 2025, 6,500 RSOs remained outstanding and unexercised.

There was no net income tax benefit recognized relating to stock-based compensation expense and no tax benefits have been realized from RSGs or RSOs due to the full valuation allowance during the three and six months ended June 30, 2025 and 2024.

During the three and six months ended June 30, 2025 and 2024, the Company issued RSUs and PSUs with various vesting conditions, as further described below. All of the RSUs and PSUs contain performance-based vesting conditions, none of which have been deemed probable as of June 30, 2025. Thus, no stock compensation expense for these awards has been recognized to-date. In the period in which a qualifying event is probable, the Company will record a cumulative one-time stock-based compensation expense determined using the grant-date fair values. Stock-based compensation related to remaining time-based service after the qualifying event will be recorded over the remaining requisite service period using an accelerated attribution method. The total unrecognized share-based compensation expense related to the RSUs was $115.2 million as of June 30, 2025. Of this amount, $78.1 million relates to awards for which the time-based vesting condition has been satisfied or partially satisfied, while $37.1 million relates to awards for which the time-based vesting condition had not yet been satisfied. The total unrecognized share-based compensation expense related to the PSUs was approximately $38.6 million as of June 30, 2025.

*Restricted Stock Units*

RSUs issued through June 30, 2025 and December 31, 2024 generally follow a time-based vesting schedule whereby 25% of the award vests twelve months from the vesting commencement date, and 6.25% vest quarterly thereafter, provided the grantee remains continuously employed by the Company through each vesting date. The Board will also occasionally grant, at its discretion, RSUs that have no time-based vesting requirements and are only subject to the performance-based vesting requirement described below. In addition, the Board retains the authority to grant future shares with different terms. The RSUs are also subject to performance-based vesting, and will only satisfy this requirement on the first of the following to occur: (i) immediately prior to a Company sale event or (ii) the Company's Initial Public Offering. RSUs granted but not vested expire seven years after the grant date.

The grant-date fair value of RSUs is estimated based on the fair value of our Common Stock on the date of grant. The Company considers numerous objective and subjective factors to determine the fair value of our Common Stock including: sales of our Common Stock to third-party investors in arms-length transactions, our operating and financial performance, the valuation of comparable companies, the lack of marketability, and general and industry specific economic outlook, amongst other factors.

The following table summarizes the activity related to our RSUs for the six months ended June 30, 2025:

---

| | | |
|:---|:---|:---|
| | **Number of RSUs** | **Weighted-average grant date fair value** |
| Unvested restricted stock at December 31, 2024 | 8240247 | $12.43 |
| &nbsp;&nbsp;&nbsp;&nbsp;Granted | 1191715 | 15.90 |
| &nbsp;&nbsp;&nbsp;&nbsp;Forfeited | (376868) | 13.90 |
| &nbsp;&nbsp;&nbsp;&nbsp;Expired | (144250) | 6.00 |
| Unvested restricted stock at June 30, 2025 | 8910844 | $12.93 |

---

*Performance Stock Units*

In January 2025, the Company granted 3,018,867 PSUs to certain Company executives with a grant date fair value of $12.80 per share. The PSUs will vest upon the occurrence of the first of the following: (i) immediately prior to a sale event that values the company at a certain target price or more (the "Target Price"), (ii) the Company's Initial Public Offering at a valuation of at least the Target Price, or (iii) the Company being valued on a national securities exchange at the Target Price. Each of the three vesting conditions previously listed include both a

------

performance condition and a market condition as defined under FASB ASC 718, *Compensation - Stock Compensation*. All vesting conditions also require continued service.

Due to the market conditions included within each vesting scenario described above, the Company estimated the grant date fair value of the PSUs using a Monte Carlo option pricing model which requires Level 3 fair value inputs. The Company considers numerous objective and subjective factors to determine the fair value of our Common Stock including: sales of our Common Stock to third-party investors in arms-length transactions, our operating and financial performance, the valuation of comparable companies, the lack of marketability, and general and industry specific economic outlook, amongst other factors. Volatility used in the models is derived from the historical volatility of certain publicly traded companies. The risk-free rate included in the models was calculated using the U.S. Treasury daily yield curve and is continuously compounded in the models. The key assumptions used to calculate the grant date fair value of the PSUs were as follows:

---

| | |
|:---|:---|
| Fair value of Common Stock | $15.90 |
| Expected Volatility | 59% |
| Expected Dividends | —% |
| Risk-Free Rate | 4.30% |
| Expected term (in years) | 3.98 |

---

***401(k) Plan***

Effective January 1, 2020, the Company established an employer-sponsored employee retirement 401(k) plan. All of our employees qualify to participate under the plan criteria. Participants may elect to contribute any portion of their annual compensation up to the maximum limit imposed by federal tax law. For the periods presented, the Company made non-elective contributions to each employee equal to 3% of their compensation. For the three months ended June 30, 2025 and 2024, contributions totaled approximately $335,000 and $388,000 respectively. For the six months ended June 30, 2025 and 2024, contributions totaled approximately $686,000 and $784,000 respectively.

**11. Income Tax**

Our income tax benefit (expense) was $0 for the three and six months ended June 30, 2025 and 2024.

The Company recognizes a valuation allowance which reduces the deferred tax assets to the amount we believe these assets are more likely than not to be realized. In making such a determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and results of recent operations. If the Company determines that it would be able to realize our deferred tax assets in the future in excess of their net recorded amount, the Company would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes. As of June 30, 2025 and December 31, 2024, the value of the deferred tax asset, net of the valuation allowance, was $0.

The Company's effective tax rate for both 2025 and 2024 was 0% and differs from the statutory rate of 21% primarily as a result of our valuation allowance in both years, which fully offsets net deferred tax assets.

**12. Convertible Preferred Stock and Stockholders' Equity**

***Preferred Stock***

The outstanding shares of Series A convertible preferred stock are not mandatorily or otherwise redeemable. The sale of all, or substantially all, of the Company's assets, a consolidation or merger with another company, or a transfer of voting control in excess of fifty percent (50%) of the Company's voting power are all events which are deemed to be a liquidation and would trigger the payment of liquidation preferences under the Company's Certificate of Incorporation. The significant terms of outstanding Series A preferred shares are as follows:

------

*<u>Conversion</u>* – Each share of Series A is convertible, at the option of the holder, initially, into one share of Class A Common Stock (subject to adjustments for events of dilution). Each share of convertible preferred stock will automatically be converted upon: (i) the election of a majority of the outstanding shares of such series of preferred stock; or (ii) the consummation of an underwritten registered public offering with aggregate proceeds in excess of $35 million (a "Qualified Public Offering"). The Company's Certificate of Incorporation contains certain anti-dilution provisions, whereby if the Company issues additional shares of capital stock for an effective price lower than the conversion price for a series of preferred stock immediately prior to such issue, then the existing conversion price of such series of preferred stock will be reduced. The Company determined that while its convertible preferred stock contains certain anti-dilution features, the conversion feature embedded within its convertible preferred stock does not require bifurcation under the guidance of FASB ASC 815, *Derivatives and Hedging Activities*.

*<u>Liquidation preference</u>* – Upon any liquidation, winding up or dissolution of the Company, whether voluntary or involuntary (a "Liquidation Event"), before any distribution or payment will be made to the holders of any Common Stock, the holders of convertible preferred stock will be entitled to receive, by reason of their ownership of such stock, an amount per share of Series A equal to $2.1872 (as adjusted for stock splits, recapitalizations and other similar events) plus all declared and unpaid dividends (the "Series A Preferred Liquidation Preference"). However, if, upon any such Liquidation Event, our assets are insufficient to make payment in full to all holders of convertible preferred stock of their respective liquidation preferences, then the entire balance of the Company's assets legally available for distribution will be distributed with equal priority between the preferred holders based upon the amount of each such holders' Series A Preferred Liquidation Preference. Any excess assets, after payment in full of the liquidation preferences to the convertible preferred stockholders, are then allocated to the holders of the Common Stock, pro-rata.

*<u>Dividends</u>* – If and when declared by the Board, the holders of Series A and Common Stock, on a pari passu basis, will be entitled to receive dividends. As of June 30, 2025 and December 31, 2024 we have not declared any dividends on preferred stock or Common Stock.

*<u>Voting rights</u>* – Generally, preferred stockholders have one vote for each share of Common Stock that would be issuable upon conversion of preferred stock. Voting as a separate class, the Series A stockholders are entitled to elect one member of the Board. The holders of Common Stock, voting as a separate class, are entitled to elect two members of the Board. The remaining two members are elected by the preferred stockholders and common stockholders voting together as a single class on an as-if-converted to Common Stock basis. The Company has adopted a dual-class Common Stock structure, pursuant to which each share of Class A Common Stock will have one vote per share and each share of Class F Common Stock will have ten votes per share.

The Company has classified the Series A convertible preferred stock as mezzanine equity in accordance with FASB ASC 480, *Distinguishing Liabilities from Equity*, as the shares have certain redemption features within the liquidation preference upon a change of control that are not solely in control of the Company. The Series A convertible preferred stock is not currently redeemable because the deemed liquidation provision related to a change in control is considered a substantive condition that is contingent on an event and it is not currently probable that it will become redeemable. The carrying value of the Series A convertible preferred stock, which includes the proceeds received upon issuance, has not been adjusted to liquidation value since the securities are not currently redeemable or probable to become redeemable. Subsequent adjustments to increase the carrying value to the liquidation value will be made only if and when it becomes probable that a change in control or other deemed liquidation event will occur.

***Common Stock***

*Class A Common Stock*

As of June 30, 2025 and December 31, 2024, there were 2,891,359 shares and 2,888,859 shares issued and 2,458,394 shares and 2,455,894 shares outstanding. Holders of our Class A Common Stock are entitled to one (1) vote for each share held of record on all matters submitted to a vote of stockholders.

------

*Class F Common Stock*

In April of 2014, the Company issued 10,000,000 shares of Class F Common Stock to Daniel Miller and to Benjamin Miller, with a par value of $0.0001 per share. Each share of the Class F Common Stock is entitled to ten (10) votes per share. As of June 30, 2025 and December 31, 2024, there were 10,000,000 shares of Class F Common Stock issued and outstanding.

*Class B Common Stock*

On January 19, 2017, the Board of the Company created a new class of Common Stock, to be designated as Class B Common Stock, with a par value of $0.0001 per share. As of June 30, 2025 and December 31, 2024, 38,000,000 shares have been authorized as Class B Common Stock. As of June 30, 2025 and December 31, 2024 respectively, there were 21,827,447 and 21,540,781 shares of Class B Common Stock issued and 19,949,041 and 20,075,183 shares outstanding. Except as required by applicable law, the holders of our Class B Common Stock are not entitled to vote on any matters submitted to a vote of stockholders.

***Investors' Rights Agreement***

In 2014 we entered into an Investors' Rights Agreement (the "IRA") with certain holders of our Class F Common Stock and Series A Preferred Stock, including persons who held more than 10% of any class of our outstanding capital stock, certain of our executive officers and directors and entities with which certain of our directors are affiliated. Pursuant to the IRA, the holders of certain shares of our Common Stock and preferred stock are entitled to certain registration rights, information rights, and preemptive rights.

***Right of First Refusal and Co-Sale Agreement***

In 2014, we entered into a Right of First Refusal and Co-Sale Agreement (the "Co-Sale Agreement") with certain holders of our Common Stock and preferred stock, including persons who hold more than 10% of our outstanding capital stock, certain of our executive officers and directors, and entities with which certain of our directors are affiliated. Pursuant to the Co-Sale Agreement, the holders of our preferred stock have rights of first refusal and co-sale with respect to certain transfers made by certain holders of our Common Stock.

***Voting Agreement***

In 2014 we entered into a Voting Agreement (the "Voting Agreement") with certain holders of our Class F Common Stock and Series A Preferred Stock, including persons who held more than 10% of any class of our outstanding capital stock, our executive officers and directors, and entities with which certain of our directors are affiliated. Pursuant to the Voting Agreement, the holders of certain shares of our Common Stock and preferred stock have agreed to vote their shares on certain matters, including with respect to the election of directors.

**13. Segment and Geographic Information**

The Company operates and manages its business as one reportable and operating segment, which comprises all of Rise Companies and its consolidated subsidiaries. The consolidated financial results of Rise Companies are reported to the chief operating decision maker (the "CODM"), who the Company determined is a committee of its Chief Executive Officer and Chief Operating Officer. To assess the performance of the Company and make decisions on future resource allocation and other key operating strategies, the CODM reviews net income (loss) as reported in the condensed consolidated statements of operations. Significant segment expenses within net income (loss) include cost of revenue, technology and product development, marketing, general, administrative and other, and depreciation and amortization which are each presented separately on the condensed consolidated statements of operations. Other segment expenses include income tax benefit (expense), which is presented separately on the condensed consolidated statements of operations. Refer to the condensed consolidated financial statements for other financial information regarding the Company's operating segment. The CODM does not review assets in evaluating the results of the Company's operating segment, and therefore such information is not presented.

------

The Investment Products earn various fees, as further described in *<u>[Note 2](#i5cbf7481bb95420f96a80d958b433a8c_73)</u>, Summary of Significant Accounting Policies*—*Revenue Recognition* of its annual consolidated financial statements, which are included in the Form 10. All of the Company's investors, assets, and operations are located in the United States.

**14. Variable Interest Entities**

Pursuant to GAAP consolidation guidance, the Company consolidates certain VIEs for which it is the primary beneficiary. As of June 30, 2025 and December 31, 2024 the Company consolidated Fundrise LP. Rise Companies acts as the General Partner of Fundrise LP through a wholly-owned subsidiary, holds a 2% ownership interest in Fundrise LP and has the ability to manage its assets. The Company does not provide performance guarantees and has no other financial obligation to provide funding to Fundrise LP. The assets of Fundrise LP may only be used to settle obligations of Fundrise LP. In addition, there is no recourse to the Company for Fundrise LP's liabilities.

The non-controlling interests ("NCI") are related to the limited partner holdings in Fundrise LP in which we have a controlling financial interest. NCI as of June 30, 2025 and December 31, 2024, respectively, was $11,901,000 and $11,627,000. As of June 30, 2025 and December 31, 2024, the assets in the limited partnership were primarily cash and cash equivalents, notes receivable, and investments in the Sponsored Programs.

The Company holds variable interests in certain VIEs which are not consolidated as it is determined that the Company is not the primary beneficiary, including its investments in the eREITs, eFund, oFund, and the Credit Fund as of June 30, 2025 and December 31, 2024. The Company's involvement with such entities is in the form of direct equity interests and fee arrangements. The maximum exposure to loss represents the loss of assets recognized by the Company relating to non-consolidated VIEs. The Company's maximum exposure to loss relating to non-consolidated VIEs were as follows (*in thousands*):

---

| | | |
|:---|:---|:---|
| | **June 30, 2025** | **December 31, 2024** |
| Investment in Sponsored Programs | $919 | $888 |
| Due from affiliates | 2538 | 2592 |
| Other current assets, net | 14 | 29 |
| Other assets, net | 1846 | 1846 |
| Maximum Exposure to Loss | $**5317** | $**5355** |
| Amounts Due to Non-Consolidated VIEs | $131 | $— |

---

**15. Related Party Transactions**

In addition to those disclosed elsewhere in the notes to the condensed consolidated financial statements, the following related party transactions are disclosed:

***Affiliate Receivables and Payables***

Due from affiliate receivables consist of the following (*in thousands*):

---

| | | |
|:---|:---|:---|
| | **June 30, 2025** | **December 31, 2024** |
| Investment management and platform advisory receivables | $3915 | $3947 |
| Real estate management receivables | 73 | 887 |
| Real estate operating platform receivables | 1542 | 1529 |
| Other receivables from affiliates | 1219 | 784 |
| **Total**  | $**6749** | $**7147** |

---

Deferred costs of the Sponsored Programs are approximately $1,846,000 and are included in Other assets, net on the condensed consolidated balance sheets as of June 30, 2025 and December 31, 2024, respectively. Amounts

------

due to affiliates are approximately $175,000 and $626,000 and are included in Other current liabilities and Accrued expenses on the condensed consolidated balance sheets as of June 30, 2025 and December 31, 2024, respectively.

***Investments in Sponsored Programs by Company's Executives***

Many of the Company's executive officers and directors (including immediate family members) have opened investor accounts on the Fundrise Platform. All investments (and redemptions, where applicable) were made in the ordinary course of business and transacted on terms and conditions that were not more favorable than those obtained by third-party investors.

***Fundrise LP Promissory Notes***

National Lending, LLC ("National Lending") is a self-sustaining lending entity, financed by certain of the Sponsored Programs. Rise became the manager of National Lending effective June 18, 2025, but does not hold any equity interest in National Lending or otherwise have the power to direct the activities of National Lending. Prior to this change, an independent manager managed National Lending under a management agreement at a market rate. On July 1, 2024, Fundrise LP made a loan of $2.75 million to National Lending. The loan carried an annual interest rate of 5.75% and matured on December 31, 2024. On December 31, 2024, National Lending repaid the outstanding principal and interest on the promissory note made by Fundrise LP in accordance with the terms of the loan agreement. On October 1, 2024, Fundrise LP made a loan of $9.0 million to National Lending. The loan carries an annual interest rate of 5.25% and is set to mature on September 30, 2025. On December 31, 2024, Fundrise LP made another loan of $3.5 million to National Lending. The loan carries an annual interest rate of 4.75% and is set to mature on December 31, 2025.

For the periods presented, the balances for the outstanding loans from Fundrise LP are included in Notes receivable on the condensed consolidated balance sheets and the accrued interest on the notes is included in Other current assets, net on the condensed consolidated balance sheets.

***Redemption of Investments in Sponsored Programs***

On April 9, 2024, Fundrise LP redeemed its investments in the following Sponsored Programs: Fundrise Real Estate Interval Fund, LLC, Fundrise Income Real Estate Fund, LLC, Fundrise Midland Opportunistic REIT, LLC, Fundrise Growth eREIT III, LLC, Fundrise Growth eREIT VII, LLC and Fundrise Balanced eREIT II, LLC. Fundrise LP received $1,772,000 from the redemption, resulting in a gain on the disposition of $587,000. On September 4, 2024, Fundrise LP redeemed its investment in the Fundrise eFund for $307,000, resulting in a gain on the disposition of $18,000.

**16. Commitments and Contingencies**

***Liquidation Support Agreement – Fundrise Equity REIT, LLC***

To mitigate the effect of one of our initial Sponsored Programs, Fundrise Equity REIT, LLC's, lack of assets, revenue, and operating history, Fundrise Advisors agreed to make a payment to Fundrise Equity REIT, LLC of up to $500,000 if the distributions paid upon liquidation (together with any distributions made prior to liquidation) are less than a 20% average annual non-compounded return. This is a contingent liability that was not probable and therefore not accrued as of June 30, 2025 or December 31, 2024. The following table details the amount of payment at varying levels of return (*in thousands*):

---

| | |
|:---|:---|
| **Average Annual Non-Compounded Return** | **Liquidation Support Payment** |
| 17.0% or less | $500 |
| 17.1% to 18.0% | $400 |
| 18.1% to 19.0% | $300 |
| 19.1% to 19.9% | $200 |
| 20.0% or greater | $— |

---

------

***Legal Proceedings***

As of the date of these condensed consolidated financial statements, we are not currently named as a defendant in any active or pending material litigation. However, it is possible that the Company could become involved in various litigation matters arising in the ordinary course of our business. Although we are unable to predict with certainty the eventual outcome of any litigation, management is not aware of any litigation likely to occur that we currently assess as being significant to us.

**17. Subsequent Events**

Management has evaluated subsequent events for potential recognition or disclosure in these condensed consolidated financial statements through August 8, 2025, which was the date the condensed consolidated financial statements were available to be issued.

***iPO Proceeds***

Effective October 30, 2024, the Company's latest offering statement was qualified by the SEC. Since the report date through the date of this filing, we have raised approximately $1.3 million from settled subscriptions.

***Tax Legislation Changes***

On July 4, 2025, the One Big Beautiful Bill Act (the "OBBBA") was signed into law, which makes permanent many of the tax provisions enacted in 2017 as part of the Tax Cuts and Jobs Act that were set to expire at the end of 2025, including 100% bonus depreciation, domestic research cost expensing, and the business interest expense limitation. In addition, the OBBBA makes changes to certain U.S. corporate tax provisions, but many are generally not effective until 2026. The Company is currently evaluating the potential impacts of the OBBBA; however, it is not expected to have a material impact on the Company's condensed consolidated financial statements.

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

The following discussion of our financial condition and results of operations should be read in conjunction with the financial statements and notes thereto appearing elsewhere in this Quarterly Report. The following discussion contains forward-looking statements. See "Statements Regarding Forward-Looking Information" within this Quarterly Report.

**Business**

Rise Companies is a Delaware corporation that was formed on March 10, 2014. Our office is located at 11 Dupont Circle NW, 9th Floor, Washington, D.C. 20036. Our telephone number is (202) 584-0550. Information regarding the Company is also available on our web site at *<u>www.fundrise.com</u>*. The Company, together with its subsidiaries and affiliate organizations ("Fundrise"), combines modern financial technology and investment management to build the next generation of alternative asset management. Refer to *<u>[Note](#i5cbf7481bb95420f96a80d958b433a8c_70)[1](#i5cbf7481bb95420f96a80d958b433a8c_70)</u>, Formation and Organization* to the Condensed Consolidated Financial Statements for a description of our corporate structure and affiliated entities.

The Fundrise Platform has allowed us to build a differentiated business with what we believe is a significant competitive advantage and a robust, proprietary software infrastructure. We generate revenue from investment management and platform advisory fees, real estate management fees, and real estate operating platform fees which are detailed in *<u>[Note 4](#i5cbf7481bb95420f96a80d958b433a8c_79)</u>, Revenue* in the Notes to our Condensed Consolidated Financial Statements included in this Quarterly Report.

We own and operate the Fundrise Platform, a leading web-based and mobile alternative asset investment platform. We use industry-specific expertise to evaluate, originate, service and manage investment opportunities through our fund management. We seek to develop alternative investment vehicles for external investors, for which we provide asset management services, typically under long-term management arrangements either through a contract with, or as the manager or general partner of, our Investment Products.

------

We limit our investment vehicle development and management services to asset classes where we have specific expertise. We believe this strategy enhances the return on investment we can achieve for our investment vehicles.

As of June 30, 2025, the Investment Products have total assets under management ("AUM") of $2.94 billion with over 399,000 active investor accounts and 2,474,000 active users on the Fundrise Platform.

**Results of the Business**

We are encouraged by both the performance of the alternative investments held by our Investment Products and by our own ability to navigate the evolving economic landscape. Despite ongoing challenges and macroeconomic headwinds such as persistent inflation, elevated interest rates, tariffs and volatility in real estate markets, our investments continue to demonstrate resilience.

As of June 30, 2025, we have yet to generate any profits from our operations and are incurring net losses while we invest in the development and expansion of our business. For the six months ended June 30, 2025 and the year ended December 31, 2024, we continued to focus on increasing efficiency as part of our drive towards future profitability.

Refer to *<u>[Note 17](#i5cbf7481bb95420f96a80d958b433a8c_2199023256187)</u>, Subsequent Events* to the Condensed Consolidated Financial Statements for more details on recent developments.

**Results of Operations**

***Three Months Ended June 30, 2025 Compared to the Three Months Ended June 30, 2024***

For the three months ended June 30, 2025 and 2024, our results of operations are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Results** | **Three Months Ended<br>June 30, 2025**<br>*(in thousands)* | **Three Months Ended<br>June 30, 2024**<br>*(in thousands)* | **% Change**<br>*(from 2024)* | **Explanation** |
| **Revenue** | **Revenue** | **Revenue** | **Revenue** | **Revenue** |
| Investment management and platform advisory, net | $8003 | $7719 | 4% | Investment management and platform advisory income, net remained consistent due to relatively consistent average AUM period-over-period.  |
| Real estate management | 3432 | 3031 | 13% | The increase in real estate management revenues period-over-period is driven by an increase in capital markets and origination fees earned from an increase in deal-related activity. |
| Real estate operating platform | 4633 | 4514 | 3% | Real estate operating platform income remained consistent due to relatively consistent underlying asset values period-over-period. |
| **Total operating revenue**  | $**16068** | $**15264** | **5%** |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Results** | **Three Months Ended<br>June 30, 2025**<br>*(in thousands)* | **Three Months Ended<br>June 30, 2024**<br>*(in thousands)* | **% Change**<br>*(from 2024)* | **Explanation** |
| **Costs and Expenses** | **Costs and Expenses** | **Costs and Expenses** | **Costs and Expenses** | **Costs and Expenses** |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Results** | **Three Months Ended<br>June 30, 2025**<br>*(in thousands)* | **Three Months Ended<br>June 30, 2024**<br>*(in thousands)* | **% Change**<br>*(from 2024)* | **Explanation** |
| Cost of revenue, exclusive of depreciation and amortization shown separately below | Cost of revenue, exclusive of depreciation and amortization (which are shown separately below), consists primarily of: (i) allocated salaries and benefits for employees responsible for investor relations and service; (ii) salaries and benefits of personnel associated with real estate services such as closing of real estate investments and real estate asset management; and (iii) costs associated with maintaining the Fundrise Platform including cloud infrastructure costs, third-party expenses, and salaries and benefits of personnel responsible for the ongoing operations and delivery of our platform. | Cost of revenue, exclusive of depreciation and amortization (which are shown separately below), consists primarily of: (i) allocated salaries and benefits for employees responsible for investor relations and service; (ii) salaries and benefits of personnel associated with real estate services such as closing of real estate investments and real estate asset management; and (iii) costs associated with maintaining the Fundrise Platform including cloud infrastructure costs, third-party expenses, and salaries and benefits of personnel responsible for the ongoing operations and delivery of our platform. | Cost of revenue, exclusive of depreciation and amortization (which are shown separately below), consists primarily of: (i) allocated salaries and benefits for employees responsible for investor relations and service; (ii) salaries and benefits of personnel associated with real estate services such as closing of real estate investments and real estate asset management; and (iii) costs associated with maintaining the Fundrise Platform including cloud infrastructure costs, third-party expenses, and salaries and benefits of personnel responsible for the ongoing operations and delivery of our platform. | Cost of revenue, exclusive of depreciation and amortization (which are shown separately below), consists primarily of: (i) allocated salaries and benefits for employees responsible for investor relations and service; (ii) salaries and benefits of personnel associated with real estate services such as closing of real estate investments and real estate asset management; and (iii) costs associated with maintaining the Fundrise Platform including cloud infrastructure costs, third-party expenses, and salaries and benefits of personnel responsible for the ongoing operations and delivery of our platform. |
| Cost of revenue, exclusive of depreciation and amortization shown separately below | $2248 | $2226 | 1% | Cost of revenue expenses remained consistent period-over-period. |
| Technology and product development | Technology and product development expenses consist primarily of salaries and benefits for teams responsible for software engineering, product development, technology activities, as well as costs for third-party software. Technology and product development costs exclude capitalized internal-use software development costs, as they are capitalized as a component of property, software and equipment, net, and amortized through depreciation and amortization over the terms of their respective useful lives. All other Technology and product development expenses are expensed as incurred. | Technology and product development expenses consist primarily of salaries and benefits for teams responsible for software engineering, product development, technology activities, as well as costs for third-party software. Technology and product development costs exclude capitalized internal-use software development costs, as they are capitalized as a component of property, software and equipment, net, and amortized through depreciation and amortization over the terms of their respective useful lives. All other Technology and product development expenses are expensed as incurred. | Technology and product development expenses consist primarily of salaries and benefits for teams responsible for software engineering, product development, technology activities, as well as costs for third-party software. Technology and product development costs exclude capitalized internal-use software development costs, as they are capitalized as a component of property, software and equipment, net, and amortized through depreciation and amortization over the terms of their respective useful lives. All other Technology and product development expenses are expensed as incurred. | Technology and product development expenses consist primarily of salaries and benefits for teams responsible for software engineering, product development, technology activities, as well as costs for third-party software. Technology and product development costs exclude capitalized internal-use software development costs, as they are capitalized as a component of property, software and equipment, net, and amortized through depreciation and amortization over the terms of their respective useful lives. All other Technology and product development expenses are expensed as incurred. |
| Technology and product development | $4735 | $3378 | 40% | Technology and product development expenses increased period-over-period due to fewer salaries and benefits being capitalized to internal-use software. |
| Marketing | Marketing expenses consist primarily of the costs associated with engaging and enrolling investors in the Investment Products, including costs attributable to marketing our products. This primarily includes costs of building general brand awareness, and salaries and benefits expenses related to our marketing and design teams. | Marketing expenses consist primarily of the costs associated with engaging and enrolling investors in the Investment Products, including costs attributable to marketing our products. This primarily includes costs of building general brand awareness, and salaries and benefits expenses related to our marketing and design teams. | Marketing expenses consist primarily of the costs associated with engaging and enrolling investors in the Investment Products, including costs attributable to marketing our products. This primarily includes costs of building general brand awareness, and salaries and benefits expenses related to our marketing and design teams. | Marketing expenses consist primarily of the costs associated with engaging and enrolling investors in the Investment Products, including costs attributable to marketing our products. This primarily includes costs of building general brand awareness, and salaries and benefits expenses related to our marketing and design teams. |
| Marketing | $1991 | $2011 | -1% | Marketing expense remained consistent period-over-period. |
| General, administrative and other | General, administrative and other expenses consist primarily of salaries and benefits for our corporate functions (including finance, legal, human resources, and IT operations), as well as other software and office expenses, and professional fees. | General, administrative and other expenses consist primarily of salaries and benefits for our corporate functions (including finance, legal, human resources, and IT operations), as well as other software and office expenses, and professional fees. | General, administrative and other expenses consist primarily of salaries and benefits for our corporate functions (including finance, legal, human resources, and IT operations), as well as other software and office expenses, and professional fees. | General, administrative and other expenses consist primarily of salaries and benefits for our corporate functions (including finance, legal, human resources, and IT operations), as well as other software and office expenses, and professional fees. |
| Software and other office expenses | $687 | $700 | -2% | Software and other office expenses remained consistent period-over-period and are mainly comprised of software subscription expenses supporting corporate functions and corporate office lease expense. |
| Professional fees | 784 | 336 | 133% | Professional fees increased period-over-period due to an increase in legal fees for certain advisory projects. |
| Other general and administrative | 4548 | 4982 | -9% | Other general and administrative expenses are comprised mainly of salaries and benefits of personnel responsible for our corporate functions, which decreased period-over-period due to a decrease in headcount. |
| Depreciation and amortization | Depreciation and amortization expense consists of depreciation expense for our fixed assets and amortization expense for certain software development costs. | Depreciation and amortization expense consists of depreciation expense for our fixed assets and amortization expense for certain software development costs. | Depreciation and amortization expense consists of depreciation expense for our fixed assets and amortization expense for certain software development costs. | Depreciation and amortization expense consists of depreciation expense for our fixed assets and amortization expense for certain software development costs. |
| Depreciation and amortization | $3030 | $2260 | 34% | Depreciation and amortization expense increased period-over-period due to an increase in amortization of internal use software as more projects were in service in the second quarter of 2025 compared to the second quarter of 2024. |
| **Total operating expenses**  | $**18023** | $**15893** | **13%** |  |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Results** | **Three Months Ended<br>June 30, 2025**<br>*(in thousands)* | **Three Months Ended<br>June 30, 2024**<br>*(in thousands)* | **% Change**<br>*(from 2024)* | **Explanation** |
| **Other Income** | **Other Income** | **Other Income** | **Other Income** | **Other Income** |
| Gain on disposition of investments |  | 587 | -100% | Fundrise LP, an affiliate of Rise, redeemed its investment in certain of the Investment Products over the course of 2024, resulting in a gain on disposition. Refer to *<u>[Note 15](#i5cbf7481bb95420f96a80d958b433a8c_115)</u>, Related Party Transactions* in the Notes to the Condensed Consolidated Financial Statements for more details.  |
| Dividend and interest income | 253 | 495 | -49% | Dividend and interest income decreased period-over-period largely due to a decrease in sweep dividends earned, due to a lower average daily cash balance and lower rates. |
| Equity in earnings  | 30 | 4 | 650% | Equity in earnings earned from Rise and its subsidiaries' investments in the Investment Products increased period-over-period due to the Investment Products' increased net earnings period-over-period.  |
| **Total other income**  | $**283** | $**1086** | **(74)%** |  |

---

***Six Months Ended June 30, 2025 Compared to the Six Months Ended June 30, 2024***

For the six months ended June 30, 2025 and 2024, our results of operations are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Results** | **Six Months Ended<br>June 30, 2025**<br>*(in thousands)* | **Six Months Ended<br>June 30, 2024**<br>*(in thousands)* | **% Change**<br>*(from 2024)* | **Explanation** |
| **Revenue** | | | | |
| Investment management and platform advisory, net | $15826 | $15410 | 3% | Investment management and platform advisory income, net remained consistent due to relatively consistent average AUM period-over-period.  |
| Real estate management | 4380 | 4293 | 2% | Real estate management income remained consistent due to similar real estate deal activity period-over-period.  |
| Real estate operating platform | 9277 | 8835 | 5% | Real estate operating platform income increased due to increases in underlying asset values period-over-period. |
| **Total operating revenue**  | $**29483** | $**28538** | **3%** |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Results** | **Six Months Ended<br>June 30, 2025**<br>*(in thousands)* | **Six Months Ended<br>June 30, 2024**<br>*(in thousands)* | **% Change**<br>*(from 2024)* | **Explanation** |
| **Costs and Expenses** |  |  |  |  |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| Cost of revenue, exclusive of depreciation and amortization shown separately below | Cost of revenue, exclusive of depreciation and amortization shown separately below, consists primarily of: (i) allocated salaries and benefits for employees responsible for investor relations and service; (ii) salaries and benefits of personnel associated with real estate services such as closing of real estate investments and real estate asset management; and (iii) costs associated with maintaining the Fundrise Platform including cloud infrastructure costs, third-party expenses, and salaries and benefits of personnel responsible for the ongoing operations and delivery of our platform. | Cost of revenue, exclusive of depreciation and amortization shown separately below, consists primarily of: (i) allocated salaries and benefits for employees responsible for investor relations and service; (ii) salaries and benefits of personnel associated with real estate services such as closing of real estate investments and real estate asset management; and (iii) costs associated with maintaining the Fundrise Platform including cloud infrastructure costs, third-party expenses, and salaries and benefits of personnel responsible for the ongoing operations and delivery of our platform. | Cost of revenue, exclusive of depreciation and amortization shown separately below, consists primarily of: (i) allocated salaries and benefits for employees responsible for investor relations and service; (ii) salaries and benefits of personnel associated with real estate services such as closing of real estate investments and real estate asset management; and (iii) costs associated with maintaining the Fundrise Platform including cloud infrastructure costs, third-party expenses, and salaries and benefits of personnel responsible for the ongoing operations and delivery of our platform. | Cost of revenue, exclusive of depreciation and amortization shown separately below, consists primarily of: (i) allocated salaries and benefits for employees responsible for investor relations and service; (ii) salaries and benefits of personnel associated with real estate services such as closing of real estate investments and real estate asset management; and (iii) costs associated with maintaining the Fundrise Platform including cloud infrastructure costs, third-party expenses, and salaries and benefits of personnel responsible for the ongoing operations and delivery of our platform. |
| Cost of revenue, exclusive of depreciation and amortization shown separately below | $4466 | $4635 | -4% | Cost of revenue expenses remained consistent period-over-period. |
| Technology and product development | Technology and product development expenses consist primarily of salaries and benefits for teams responsible for software engineering, product development, technology activities, as well as costs for third-party software. Technology and product development costs exclude capitalized internal-use software development costs, as they are capitalized as a component of property, software and equipment, net, and amortized through Depreciation and amortization over the term of their useful life. All other Technology and product development expenses are expensed as incurred. | Technology and product development expenses consist primarily of salaries and benefits for teams responsible for software engineering, product development, technology activities, as well as costs for third-party software. Technology and product development costs exclude capitalized internal-use software development costs, as they are capitalized as a component of property, software and equipment, net, and amortized through Depreciation and amortization over the term of their useful life. All other Technology and product development expenses are expensed as incurred. | Technology and product development expenses consist primarily of salaries and benefits for teams responsible for software engineering, product development, technology activities, as well as costs for third-party software. Technology and product development costs exclude capitalized internal-use software development costs, as they are capitalized as a component of property, software and equipment, net, and amortized through Depreciation and amortization over the term of their useful life. All other Technology and product development expenses are expensed as incurred. | Technology and product development expenses consist primarily of salaries and benefits for teams responsible for software engineering, product development, technology activities, as well as costs for third-party software. Technology and product development costs exclude capitalized internal-use software development costs, as they are capitalized as a component of property, software and equipment, net, and amortized through Depreciation and amortization over the term of their useful life. All other Technology and product development expenses are expensed as incurred. |
| Technology and product development | $10295 | $7666 | 34% | Technology and product development expenses increased period-over-period due to fewer salaries and benefits being capitalized to internal-use software. |
| Marketing | Marketing expenses consist primarily of the costs associated with engaging and enrolling investors in the Investment Products, including costs attributable to marketing our products. This primarily includes costs of building general brand awareness, and salaries and benefits expenses related to our marketing and design teams. | Marketing expenses consist primarily of the costs associated with engaging and enrolling investors in the Investment Products, including costs attributable to marketing our products. This primarily includes costs of building general brand awareness, and salaries and benefits expenses related to our marketing and design teams. | Marketing expenses consist primarily of the costs associated with engaging and enrolling investors in the Investment Products, including costs attributable to marketing our products. This primarily includes costs of building general brand awareness, and salaries and benefits expenses related to our marketing and design teams. | Marketing expenses consist primarily of the costs associated with engaging and enrolling investors in the Investment Products, including costs attributable to marketing our products. This primarily includes costs of building general brand awareness, and salaries and benefits expenses related to our marketing and design teams. |
| Marketing | $5667 | $4227 | 34% | The increase in marketing expense period-over-period was due to increased marketing spend to grow the Fundrise Platform in the first half of 2025. |
| General, administrative and other | General, administrative and other expenses consist primarily of salaries and benefits for our corporate functions (including finance, legal, human resources, and IT operations), as well as other software and office expenses, and professional fees. | General, administrative and other expenses consist primarily of salaries and benefits for our corporate functions (including finance, legal, human resources, and IT operations), as well as other software and office expenses, and professional fees. | General, administrative and other expenses consist primarily of salaries and benefits for our corporate functions (including finance, legal, human resources, and IT operations), as well as other software and office expenses, and professional fees. | General, administrative and other expenses consist primarily of salaries and benefits for our corporate functions (including finance, legal, human resources, and IT operations), as well as other software and office expenses, and professional fees. |
| Software and other office expenses | $1337 | $1371 | -2% | Software and other office expenses remained consistent period-over-period and are mainly comprised of software subscription expenses supporting corporate functions and corporate office lease expense. |
| Professional fees | 1349 | 667 | 102% | Professional fees increased period-over-period due to an increase in legal fees for certain advisory projects. |
| Other general and administrative | 9236 | 9994 | -8% | Other general and administrative expenses are comprised mainly of salaries and benefits of personnel responsible for our corporate functions, which decreased slightly period-over-period due to a decrease in headcount. |
| Depreciation and amortization | Depreciation and amortization expense consists of depreciation expense for our fixed assets and amortization expense for certain software development costs. | Depreciation and amortization expense consists of depreciation expense for our fixed assets and amortization expense for certain software development costs. | Depreciation and amortization expense consists of depreciation expense for our fixed assets and amortization expense for certain software development costs. | Depreciation and amortization expense consists of depreciation expense for our fixed assets and amortization expense for certain software development costs. |
| Depreciation and amortization | $6066 | $4674 | 30% | Depreciation and amortization expense increased period-over-period due to an increase in amortization of internal use software as more projects were in service in the first half of 2025 compared to first half of 2024. |
| **Total operating expenses**  | $**38416** | $**33234** | **16%** |  |

---

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Results** | **Six Months Ended<br>June 30, 2025**<br>*(in thousands)* | **Six Months Ended<br>June 30, 2024**<br>*(in thousands)* | **% Change**<br>*(from 2024)* | **Explanation** |
| **Other Income** | | | | |
| Gain on extinguishment of debt | $2391 | $— | 100% | In January 2025, the Company was notified that its Paycheck Protection Program (the "PPP loan") loan in the principal amount of $2,793,800 was partially forgiven by the U.S. Small Business Administration (the "SBA") and the Company recorded a corresponding gain. Refer to *<u>[Note 8](#i5cbf7481bb95420f96a80d958b433a8c_94)</u>, Loan Payable* in the Notes to the Condensed Consolidated Financial Statements for more details.  |
| Gain on disposition of investments |  | 587 | (100)% | Fundrise LP, an affiliate of Rise, redeemed its investment in certain of the Investment Products over the course of 2024, resulting in a gain on disposition. Refer to *<u>[Note 15](#i5cbf7481bb95420f96a80d958b433a8c_115)</u>, Related Party Transactions* in the Notes to the Condensed Consolidated Financial Statements for more details.  |
| Dividend and interest income | 581 | 1060 | (45)% | Dividend and interest income decreased period-over-period largely due to a decrease in sweep dividends earned, due to a lower average daily cash balance and lower rates. |
| Equity in earnings  | 48 | 25 | 92% | Equity in earnings earned from Rise and its subsidiaries' investments in the Investment Products increased period-over-period due to the Investment Products' increase in net earnings period-over-period.  |
| **Total other income**  | $**3020** | $**1672** | **81%** |  |

---

**Key Factors Impacting Our Current Year Performance**

Our historical growth rates of the Fundrise Platform reflect a deliberate strategy that has allowed us to build and develop the various enterprise functions needed to meet the changing demands of our customers and to support our scale, including operations, risk controls, customer support, compliance and technology. The Investment Products have seen reductions in AUM in recent years due to multi-decade lows experienced in real estate prices. However, falling interest rates in 2024 and strong investment operating fundamentals drove growth in 2024 despite ongoing headwinds as a result of sustained higher borrowing costs. In the first half of 2025, our Investment Products have continued to see positive returns, despite various challenges, primarily in the real estate market. We believe that these returns stemmed primarily from the strength of the portfolio's underlying fundamentals combined with a high level of operational discipline. Demand from investors and the modern financial industry will continue to inform our business and Investment Product decisions. Given this approach and the dynamic path of our experienced and expected future growth, we have focused in 2025 on a number of important developments within our business that we believe reflect the key factors impacting our performance in 2025. Refer to the "Key Factors We Expect to Impact Our Future Performance" section below for a description of these key factors.

**Key Factors We Expect to Impact Our Future Performance**

***Investment in Long-Term Growth***

The core elements of our growth strategy include enhancing our technology infrastructure, expanding our product and feature offerings, enrolling new investors in our Investment Products, broadening our investment

------

acquisition capabilities, and extending customer lifetime value. We plan to continue to invest resources needed to accomplish these goals, and we anticipate that certain operating expenses will increase in the future as a result. These investments are intended to contribute to our long-term growth, but they may continue to affect our near-term profitability.

***Sources of Operating Revenues and Cash Flows***

We generate revenues from investment management and platform advisory fees, real estate management fees, and real estate operating platform fees, which are detailed in *<u>[Note](#i5cbf7481bb95420f96a80d958b433a8c_79)[4](#i5cbf7481bb95420f96a80d958b433a8c_79)</u>, Revenue* in the Notes to the Condensed Consolidated Financial Statements included in this Quarterly Report.

**Liquidity and Capital Resources**

We have incurred operating losses since our inception and have an accumulated deficit of $176.1 million as of June 30, 2025. We have financed our operations primarily through our operating revenues as well as the issuance of equity securities. Our ability to achieve profitability depends on our ability to generate revenue growth in existing product lines, successfully launch new product lines, and manage costs. We may continue to incur substantial operating losses while we continue to build the business and invest in new innovation.

As of June 30, 2025 and December 31, 2024, we had $11.2 million and $21.1 million in cash and cash equivalents, respectively. The decrease in our cash and cash equivalents between those periods is primarily due to an increase in certain discretionary cash outflows, including employee bonuses and other technology and product development expenses; all of which were within the discretion of the Company. We anticipate that our cash and cash equivalents as of June 30, 2025, and forecasted revenue, will provide sufficient liquidity for more than a twelve-month period from the date of filing this Quarterly Report. The actual amount of cash that we will need to operate is subject to many factors, including, but not limited to our product development and engineering efforts. We are dependent upon significant future financing, including through our Offering described below under "Other Details—Offering Results" to provide the cash necessary to execute our future operations, including the continued development of our products.

As of June 30, 2025, our material commitments for capital expenditures consisted of operating leases, as discussed in *<u>[Note 6](#i5cbf7481bb95420f96a80d958b433a8c_85)</u>, Leases* in the Notes to the Condensed Consolidated Financial Statements included in this Quarterly Report.

***Corporate Debt***

As of June 30, 2025, we had no corporate debt. As of December 31, 2024, we had corporate debt payable of approximately $2.69 million. On April 20, 2020, the Company received the PPP Loan offered by the SBA in the principal amount of $2,793,800 pursuant to Title 1 of the Coronavirus Aid, Relief and Economic Security Act ("CARES Act").

As explained more fully in *<u>[Note 8](#i5cbf7481bb95420f96a80d958b433a8c_94)</u>, Loan Payable*—*PPP Loan Payable* to the Condensed Consolidated Financial Statements in this Quarterly Report, according to the terms of the CARES Act and subsequent regulations, all or a portion of loans under the program may be forgiven if certain conditions are met. In July 2021 we applied for such forgiveness. In January 2025, the Company was notified that the PPP loan was forgiven up to the determined eligible amount of $2,315,905. On March 19, 2025, the Company repaid the remaining $0.4 million of outstanding principal.

**Other Details**

***Offering Results***

As of June 30, 2025, we are offering up to $53.5 million in shares of our Class B Common Stock (the "Offering"), which represents the shares available to be offered out of the rolling twelve-month maximum offering amount of $75.0 million under Regulation A ("Regulation A") of the Securities Act. The Offering is being conducted as a continuous offering pursuant to Rule 251(d)(3) of Regulation A, meaning that while the offering of securities is continuous, active sales of securities may occur sporadically over the term of the Offering. As of

------

June 30, 2025, we had raised total gross offering proceeds of approximately $209.2 million from settled subscriptions.

As of June 30, 2025, we have sold 21,191,892 shares of our Class B Common Stock. This does not include 635,555 shares of Class B Common Stock that were sold in private placements pursuant to Rule 506(c) of Regulation D of the Securities Act ("Regulation D").

Shares are currently offered and are sold on a continuous basis only to existing investors in the Investment Products. The funds received from the issuance of our Class B Common Stock are a source of capital for our operating expenditures.

***Off-Balance Sheet Arrangements***

As of June 30, 2025 and December 31, 2024, we had no off-balance sheet arrangements.

***Related Party Arrangements***

For further information regarding "Related Party Arrangements," please see *<u>[Note 15](#i5cbf7481bb95420f96a80d958b433a8c_115)</u>, Related Party Transactions*, in our quarterly condensed consolidated financial statements included in this Quarterly Report.

***Critical Accounting Estimates***

Management's Discussion and Analysis of Financial Condition and Results of Operations in the Quarterly Report is based on our Condensed Consolidated Financial Statements, which are prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these Condensed Consolidated Financial Statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. By their nature, these estimates and assumptions are subject to an inherent degree of uncertainty and actual results could differ significantly from the estimates made by management. To the extent that there are differences between our estimates and actual results, our future financial statement presentation, financial condition, results of operations, and cash flows will be affected. For a complete description of our accounting policies, see *<u>[Note 2](#i5cbf7481bb95420f96a80d958b433a8c_73)</u>, Summary of Significant Accounting Policies* in our annual consolidated financial statements included in the Form 10.

The Company's critical accounting estimates are disclosed in the Form 10. There have been no material changes to these estimates during the three and six months ended June 30, 2025, and no significant updates were made to the underlying methodologies or assumptions since the date of the Form 10.

***Recent Accounting Pronouncements***

The Financial Accounting Standards Board has released several Accounting Standards Updates ("ASUs") that may have an impact on our financial statements. See *<u>[Note 2](#i5cbf7481bb95420f96a80d958b433a8c_73)</u>, Summary of Significant Accounting Policies*—*Recent Accounting Pronouncements* to the Condensed Consolidated Financial Statements included in this Quarterly Report for discussion of the relevant ASUs. We are currently evaluating the impact of the ASUs not yet adopted on our financial statements and determining our plan for adoption.

**Item 3.&nbsp;&nbsp;&nbsp;&nbsp;Quantitative and Qualitative Disclosures About Market Risk**

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

**Item 4.&nbsp;&nbsp;&nbsp;&nbsp;Controls and Procedures**

***Disclosure Controls and Procedures***

An evaluation of the effectiveness of the design and operation of our "disclosure controls and procedures" (as defined in Rule 13a-15(e) under the Exchange Act), as of the end of the period covered by this Quarterly Report was made under the supervision and with the participation of our management, including our Chief Executive Officer

------

("CEO"), our principal executive officer, and our Chief Financial Officer ("CFO"), our principal financial officer. Based upon this evaluation, our CEO and CFO have concluded that our disclosure controls and procedures (a) are effective to ensure that information required to be disclosed by us in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by SEC rules and forms and (b) include, without limitation, controls and procedures designed to ensure that information required by us in reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

***Changes in Internal Control over Financial Reporting***

The disclosures otherwise required by Item 308(c) of Regulation S-K are not applicable to the Company at this time due to the transition periods provided by Exchange Act Rule 15d-15(d).

------

**PART II - OTHER INFORMATION**

**Item 1.&nbsp;&nbsp;&nbsp;&nbsp;Legal Proceedings**

As of the date of the condensed consolidated financial statements, we are not currently named as a defendant in any active or pending material litigation. However, it is possible that the Company could become involved in various litigation matters arising in the ordinary course of our business. Although we are unable to predict with certainty the eventual outcome of any litigation, management is not aware of any litigation likely to occur that we currently assess as being significant to us.

**Item 1A.&nbsp;&nbsp;&nbsp;&nbsp;Risk Factors**

We face risks and uncertainties that could affect us and our business as well as the real estate industry generally. These risks are outlined under the heading "Risk Factors" contained in the Form 10. In addition, new risks may emerge at any time and we cannot predict such risks or estimate the extent to which they may affect our financial performance. These risks could result in a decrease in the value of our common shares.

**Item 2.&nbsp;&nbsp;&nbsp;&nbsp;Unregistered Sales of Equity Securities and Use of Proceeds**

***Sales Pursuant to the Offering and our Private Placements***

On January 30, 2023, we filed with the SEC a Regulation A Offering Statement on Form 1-A (the "Offering Statement"), including our preliminary offering circular, to offer up to $75.0 million during any rolling twelve-month period of our Class B Common Stock. The SEC qualified the Offering Statement on February 13, 2023. Our Regulation A offerings are conducted as continuous offerings pursuant to Rule 251(d)(3) of Regulation A, meaning that while the offering of securities is continuous, active sales of securities may occur sporadically over the term of the respective offering. During three months ended June 30, 2025, we have sold 226,070 shares of Class B Common Stock pursuant to our Regulation A offering for aggregate proceeds of approximately $3,595,000.

In reliance upon the exemptions from registration under the Securities Act provided by Regulation A, none of the sales of our common stock described above were registered under the Securities Act.

***Repurchases of Equity Securities***

During the three months ended June 30, 2025, we repurchased shares of our Common Stock pursuant for certain discretionary investor redemptions as noted in the table below. The Company does not currently have a publicly announced share repurchase program.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total Number of Shares <br>Purchased** | **Average Price Paid Per Share** | **Total Number of Shares Purchased As Part of Publicly Announced Plans or Programs** | **Maximum Number (or Approximate Dollar value) of Shares That May Yet Be Purchased Under the Plans or Programs** |
| April 1, 2025 – April 30, 2025 |  | $— |  |  |
| May 1, 2025 – May 31, 2025 |  | $— |  |  |
| June 1, 2025 – June 30, 2025 | 210155 | $9.62 |  |  |

---

**Item 3.&nbsp;&nbsp;&nbsp;&nbsp;Defaults Upon Senior Securities**

None.

------

**Item 4.&nbsp;&nbsp;&nbsp;&nbsp;Mine Safety Disclosures**

None.

**Item 5.&nbsp;&nbsp;&nbsp;&nbsp;Other Information**

None.

**Item 6.&nbsp;&nbsp;&nbsp;&nbsp;Exhibits**

***Index to Exhibits***

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| <u>[3.1\*](https://www.sec.gov/Archives/edgar/data/1640967/000110465922069863/tm2218128d1_ex2-1.htm)</u> | <u>[Amended and Restated Certificate of Incorporation (incorporated by reference to the copy thereof](https://www.sec.gov/Archives/edgar/data/1640967/000110465922069863/tm2218128d1_ex2-1.htm)</u> <u>[submitted as Exhibit 2.1 to the Company's Form 1-U filed on June 10, 2022)](https://www.sec.gov/Archives/edgar/data/1640967/000110465922069863/tm2218128d1_ex2-1.htm)</u> |
| <u>[3.2\*](https://www.sec.gov/Archives/edgar/data/1640967/000114420417003219/v456959_ex2-2.htm)</u> | <u>[Bylaws (incorporated by reference to the copy thereof submitted as Exhibit 2.2 to the Company's](https://www.sec.gov/Archives/edgar/data/1640967/000114420417003219/v456959_ex2-2.htm)</u> <u>[Form 1-A/A filed on January 20, 2017)](https://www.sec.gov/Archives/edgar/data/1640967/000114420417003219/v456959_ex2-2.htm)</u> |
| <u>[4.1\*](https://www.sec.gov/Archives/edgar/data/1640967/000114420416141777/v455883_ex3-1.htm)</u> | <u>[Investors' Rights Agreement, by and among Rise Companies Corp. and certain investors, dated](https://www.sec.gov/Archives/edgar/data/1640967/000114420416141777/v455883_ex3-1.htm)</u> <u>[April 14, 2014 (incorporated by reference to the copy thereof submitted as Exhibit 3.1 to the Company's Form 1-A filed on December 29, 2016)](https://www.sec.gov/Archives/edgar/data/1640967/000114420416141777/v455883_ex3-1.htm)</u> |
| <u>[4.2\*](https://www.sec.gov/Archives/edgar/data/1640967/000114420416141777/v455883_ex3-2.htm)</u> | <u>[First Refusal and Co-Sale Agreement, by and among Rise Companies Corp. and certain investors,](https://www.sec.gov/Archives/edgar/data/1640967/000114420416141777/v455883_ex3-2.htm)</u> <u>[dated April 14, 2014 (incorporated by reference to the copy thereof submitted as Exhibit 3.2 to the](https://www.sec.gov/Archives/edgar/data/1640967/000114420416141777/v455883_ex3-2.htm)</u> <u>[Company's Form 1-A filed on December 29, 2016)](https://www.sec.gov/Archives/edgar/data/1640967/000114420416141777/v455883_ex3-2.htm)</u> |
| <u>[4.3\*](https://www.sec.gov/Archives/edgar/data/1640967/000110465923021297/tm233741d2_253g2.htm#APP_009)</u> | <u>[Form of Subscription Agreement (included in the Offering Circular filed on February 13, 2023 as](https://www.sec.gov/Archives/edgar/data/1640967/000110465923021297/tm233741d2_253g2.htm#APP_009)</u> <u>[Appendix A and incorporated herein by reference)](https://www.sec.gov/Archives/edgar/data/1640967/000110465923021297/tm233741d2_253g2.htm#APP_009)</u> |
| <u>[4.4\*](https://www.sec.gov/Archives/edgar/data/1640967/000114420416141777/v455883_ex5-1.htm)</u> | <u>[Voting Agreement, by and among Rise Companies Corp. and certain stockholders, dated April 14,](https://www.sec.gov/Archives/edgar/data/1640967/000114420416141777/v455883_ex5-1.htm)</u> <u>[2014 (incorporated by reference to the copy thereof submitted as Exhibit 5.1 to the Company's](https://www.sec.gov/Archives/edgar/data/1640967/000114420416141777/v455883_ex5-1.htm)</u> <u>[Form 1-A filed on December 29, 2016)](https://www.sec.gov/Archives/edgar/data/1640967/000114420416141777/v455883_ex5-1.htm)</u> |
| <u>[10.1\*](https://www.sec.gov/Archives/edgar/data/1640967/000110465923124525/tm2332377d1_ex6-1.htm)</u> | <u>[Third Amended and Restated 2014 Stock Option and Grant Plan (incorporated by reference to](https://www.sec.gov/Archives/edgar/data/1640967/000110465923124525/tm2332377d1_ex6-1.htm)</u> <u>[Exhibit 6.1 to Form 1-U filed December 8, 2023)](https://www.sec.gov/Archives/edgar/data/1640967/000110465923124525/tm2332377d1_ex6-1.htm)</u> |
| <u>[31.1](exhibit311.htm#ia5c1315ba9f24fc9a9c79a7ef85fef89_68)</u> | <u>[Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](exhibit311.htm#ia5c1315ba9f24fc9a9c79a7ef85fef89_68)</u> |
| <u>[31.2](exhibit312.htm)</u> | <u>[Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](exhibit312.htm)</u> |
| <u>[32.1](exhibit321.htm)</u>\*\* | <u>[Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](exhibit321.htm)</u> |
| <u>[32.2](exhibit322.htm)</u>\*\* | <u>[Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](exhibit322.htm)</u> |
| 101 | The following financial statements from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 formatted in inline XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheet (Unaudited), (ii) Consolidated Statement of Operations (Unaudited), (iii) Consolidated Statement of Changes in Equity (Unaudited), (v) Consolidated Statement of Cash Flows (Unaudited), and (vi) the Notes to Consolidated Financial Statements (Unaudited) |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |

---

__________________

\*Previously filed

\*\*&nbsp;&nbsp;&nbsp;&nbsp; Furnished herewith.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Benjamin S. Miller | Chief Executive Officer | August 8, 2025 |
| Benjamin S. Miller | (Principal Executive Officer) |  |
| /s/ Alison A. Staloch | Chief Financial Officer | August 8, 2025 |
| Alison A. Staloch | (Principal Financial Officer and Principal<br>Accounting Officer) |  |

---

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER**

**PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A)**

**OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED**

I, Benjamin S. Miller, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this quarterly report on Form 10-Q of Rise Companies Corp. (the "registrant");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be &nbsp;&nbsp;&nbsp;&nbsp;designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.[Intentionally omitted in accordance with Exchange Act Rule 13a-14(a)/15d-14(a)];

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| **Date:** | August 8, 2025 | */s/ Benjamin S. Miller* |
| | | Benjamin S. Miller |
| | | Chief Executive Officer |
| | | (Principal Executive Officer) |

---

## Exhibit 31.2

**EXHIBIT 31.2**

**CERTIFICATION OF CHIEF FINANCIAL OFFICER**

**PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A)**

**OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED**

I, Alison A. Staloch, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this quarterly report on Form 10-Q of Rise Companies Corp. (the "registrant");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be &nbsp;&nbsp;&nbsp;&nbsp;designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.[Intentionally omitted in accordance with Exchange Act Rule 13a-14(a)/15d-14(a)];

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| **Date:** | August 8, 2025 | */s/ Alison A. Staloch* |
| | | Alison A. Staloch |
| | | Chief Financial Officer |
| | | (Principal Financial Officer) |

---

## Exhibit 32.1

**EXHIBIT 32.1**

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the quarterly report of Rise Companies Corp. (the "Company") on Form 10-Q for the quarter ended June 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Benjamin S. Miller, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| **Date:** | August 8, 2025 | */s/ Benjamin S. Miller* |
| | | Benjamin S. Miller |
| | | Chief Executive Officer |
| | | (Principal Executive Officer) |

---

## Exhibit 32.2

**EXHIBIT 32.2**

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the quarterly report of Rise Companies Corp. (the "Company") on Form 10-Q for the quarter ended June 30, 2025 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Alison A. Staloch, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | | |
|:---|:---|:---|
| **Date:** | August 8, 2025 | */s/ Alison A. Staloch* |
| | | Alison A. Staloch |
| | | Chief Financial Officer |
| | | (Principal Financial Officer) |

---

<br>